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STRUCTURAL REQUIREMENTS FOR PROTEIN FUNCTION 
STUDIED BY IN VITRO MUTAGENESIS 
ON BETA-LACTAMASE 
ABSTRACT 
The study of naturally occurring variants of proteins 
has been successfully used for a long time to assign roles 
to structural elements in a protein and to correlate func-
tional requirements with the nature of these structural 
elements. 
Advances in techniques for DNA synthesis and DNA 
sequencing, along with the development of recombinant DNA 
techniques now allow one to clone the gene for a protein 
and then to modify it at will. In this way, presumably any 
and all aminoacid substitutions can be engineered into any 
protein whose gene has been cloned, characterized and 
expressed. 
Beta-lactamase has been used as a model system in which 
to study the feasibility of the approach, and it has been 
demonstrated that not only is it possible to introduce 
v 
specific predetermined changes in the structure of a pro-
tein, but that these mutants can in turn serve as sub-
strates for further modifications. An inactive enzyme can 
be used to search for a broad range of structural require-
ments by imposing selective conditions that require a 
function for the survival of the host organism for the 
mutant protein. 
Four variants of beta lactamase, one of which is cata-
lytically active, have been obtained by site specific 
mutagenesis. In the inactive mutants the conserved active 
site sequence -ser70-thr71- was altred to either 
-thr70-ser71- , -thr70-thr-71- or -arg-70-thr71- ; a vari-
ant in which a disulfide bond was removed by mutating one 
of the only two cysteines in E. coli beta-lactamse to ser-
ine was found to be active. In addition, a revertant to 
activity has been obtained from one of the the inactive 
mutants (-thr70-ser71-). The revertant is different in arni-
noacid sequence (-ser70-ser71-) and in some of its proper-
ties from the wild type enzyme while still having catalytic 
activity. No revertants with aminoacid substitutions at a 
secondary site were found. 
Both the catalytically active revertant and the mutant 
vi 
lacking the disulfide bridge were found to have reduced 
thermal stability. The rate of secretion of three of these 
mutants (ser70-->thr, thr71-->ser and 
ser70-->thr/thr71-->ser) was compared to that of the wild 
type beta lactamase and no significant differences were 
found. The -arg70-ser71- mutant will be used to identify 
chemical mutagens and carcinogens that induce GC to TA 
transversions by collaborators P. L. Foster and D. 
Botstein. 
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NOMENCLATURE 
Expressions of the form ser70-->thr are meant to 
indicate that a mutation which replaces serine with 
threonine at position 70 of a protein in which position 1 
is the first N terminal aminoacid, has been introduced. 
ABBREVIATIONS 
DTT is dithiothreitol, SDS is sodium dodecyl sulfate, SSC 
is 0.15 M NaCl/0.015 M sodium citrate, pH 7.0 buffer and TE 
is 10 mM Tris-HCl/1 mM EDTA pH 8.0 buffer. 
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Introduction - The linear sequence of amino acias uniquely determines the 
exquisite three-dimensional structures of proteins and their wide diver-
sity of biological function--as catalysts, hormones, transport agents , 
cell surface receptors, structural elements, transducers of chemical 
energy into work . To be able to generate, at will, any sequence of amino 
acids will therefore allow rational study of the relation between protein 
structure and function. This objective has become possible only recently 
through development of reliable methods for chemical synthesis of oligode-
oxynucleotides and DNA sequence analysis; these advances, along with 
rapidly developing cloning technology , have made possible a large variety 
of genetic manipulations that alter the structures of genes and of gene 
products. Not only do these techniques now allow one to generate essenti-
ally any variant of a prote i n to study how three dimensional structure and 
biochemical function depend on amino acid sequence, they further ensure 
that, once the DNA of the structural gene has been prepared, the protein 
can be produced ever after in any quantities desired. 
In vitro mutagenesis of a cloned structural gene of a protein can 
introduce deletions, insertions and single or multiple amino acid substi-
tutions either randoml y within a pre-selected region or at a single, 
specific s i te . In addition to these mutagenic techniques, the in vitro 
synthesis of entire structural genes has been accomplished. 1- 4 -rogether, 
these techniqoes now allow the relatively rapid construction of a protein 
with any predetermined amino acid sequence. In short, one can specify a 
particular structure and determine its function. Analogous approaches 
have, over the years, greatly enriched our resources of useful pharma-
ceuticals . The procedures characteristic of this approach are those of 
site-directed, specific mutagenesis. 
For structure-function studies of proteins, a second powerfully 
complementary approach should also be emphasized. This approach takes 
advantage of the ability of biological s y stems to produce a very large 
number of random structural variants; these can then be screened for 
those variants that have a particular function. In this case, one speci-
fies a particular function and then determines which structures, of many 
millions that can be easily tested, have that function. The procedures 
useful in this approach are those of random mutagenesis, perhaps directed 
toward a particular region of the protein . 
This review will focus particularly on those aspects of mutagenesis 
that have a direct bearing on the study of protein function. These tech-
niques have also been used to address a large variety of genetic problems 
as well as to probe structure-function relationships; the more general 
subject has been reviewed extensively.s-e 
Afoil"oi t; AL RE PORTS I !'It M EOICi"'" AL CHEM ISTR Y - 18 Cop:--nJhl ·; t98J b,- Acadmuc Prt~ . Inc 
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Amino Acid Substitutions - The roles of particular amino acid residues in 
catalysis, ligand binding, folding and in determining other properties of 
a protein can be investigated by the study of the effects on these prop-
erties of both specific and non-specific substitutions. Mutant proteins 
can be generated by methods that fall into four major categories: (a) 
deliberate, site-specific substitutions, (b) segment directed, random 
mutagenesis, (c) non-directed, random mutagenesis, and (d) suppression of 
nonsense codons generated by an appropriate mutagenic procedure. 
a. Site Specific Mutagenesis - Unique, predetermined base changes at any 
desired specific site in a structural gene, leading to any desired amino 
acid substitution in the corresponding protein, can be readily accom-
plished by oligonucleotide-directed mutagenesis; this is the most specific 
and generally applicable form of site-directed mutagenesis. First devel-
oped in the single stranded phage ~X 174, 9 • 10 this method has since been 
used to produce several point mutations in this phage; 1- 15 as well as 
in Ml3 16 and genes cloned into Ml3. 17- 19 The technique has been extended 
also to double-stranded circular DNAs. 20 - 22 
As outlined in Figure 1, this method involves priming in vitro DNA 
replication with a chemically synthesized oligodeoxynucleotide that has 
been designated to have a sequence that is largely complementary to the 
"wild-type" DNA template in the region where the mutation(s) is(are) to be 
introduced. The synthetic nucleotide contains, however, one, or more, 
Slp- Mtatd Genotyl)t 
Socttnol Cf'll 
FIGURE 1: Overoll scheme for oligonucleotide-directed mutagenesis of 
double stranded circular plasmid DNA. Supercoiled plasmid circles are 
nicked in one strand and rendered partially single stranded by treatment 
with exonuclease. The gapped circles are hybridized with a homologous 
oligodeoxynucleotide carrying, by design, some mismatches. In vitro DNA 
synthesis, primed in part by the oligodeoxynucleotide, leads to~ro­
duplex plasmid circles . Mo lecular c loning and in vivo DNA replication 
generates homoduplexes, some of which have the DNA sequence of the primer 
oli godeoxynucleoti de. Co l ony screening, with the same oligodeoxynucleo-
tide labeled with 32P as a hybridization probe, allows identification of 
the desired mut ant colony regardless of its phenotype. 
bases that are not complementary to the wild-type template; the mutation 
originates from these mismatched bases. Annealing of the synthetic oligo-
nucleotide to the wild-type circular DNA, which must of course be at least 
4 
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partially single stranded, can be accomplished under conditions of suffi-
ciently low strigency that a heteroduplex forms,in spite of some mis-
matching of bases. The site-specificity of this duplex formation is, 
nevertheless, exceedingly high. For example, in a 15 base oligodeoxynu-
cleotide there will normally be 13-14 complementary base pairings and 1-2 
mismatches at the site where the mutation is being introduced. Binding of 
the synthetic oligonucleotide to the template DNA anywhere else than at 
the desired site will generally involve no more than 9-10 pairings by 
design. The heteroduplex region thus formed now serves as an initiation 
site for in vitro DNA synthesis that occurs in the presence of the four 
deoxynucleotide triphosphates and is catalyzed by the Klenow fragment of 
DNA polymerase I (which requires a double stranded region to begin DNA 
replication). After ligation, the heteroduplex is introduced into an ap-
propriate bacterial host and multiplies as a result of normal semiconser-
vative, in vivo replication into two types of homoduplexes; the mutant 
homoduplexes have a sequence that reflects the synthetic, mutagenic oligo-
nucleotide; the other homoduplexes have the original, wild-type sequence. 
An essential feature of any procedure for producing specific mutants 
is the necessity of identifying mutant colonies in a background of wild-
type colonies. To be generally applicable, the procedure should allow 
identification of mutants at the level of DNA and not rely on some pheno-
typic difference between mutant and wild-type that may be difficult to 
predict and to assay. In this regard, oligonucleotide mutagenesis has the 
distinct advantage that mutants can be found by screening bacterial colo-
nies with the same synthetic oligonucleotide, now labeled with 32P, that 
was originally used to introduce the mutation. 19 - 22 In this case, the 
hybridization is carried out under conditions of high stringency such that 
even a single base mismatch between oligonucleotide probe and template can 
be readily distinguished from perfectly matching hybridization. This 
allows clear discrimination between wild-?ipe and mutant colonies of 
bacteria randomly spread on a Petri dish'. •' 3 
We have recently demonstrated that these procedures for oligonucleo-
tide directed mutagenesis applied to the structural gene of an expressed 
protein can be used to produce mutant proteins with amino acid substitu-
tions introduced deliberately and 'precisely, and we . have shown that these 
sequence changes can be generated with a negligible background of non-
specific mutations. 20 Both single and double base changes, leading to 
single and double amino acid substitutions, were created in the structural 
gene for S-lactamase in the double stranded circular plasmid pBR322. 
Specifically, synthetic 15 and 16 base oligomers, respectively, were u~ed 
to mutate the wild-type sequence, 5'-AGC ACT-3' (-ser70 thr71-) to 5'-AEC 
TeT-3'; (-t~r s:r-)(~ double base, and double amino acid mutation) and 
to 5'-Aec ACT-3': (tnr thr)(a single base, single amino acid mutation). 21 
Both of these mutants are catalytically inactive. (The serine residue at 
position 70 is known to be involved in catalysis 2 ~- 29 and all lactamases 
of this family have a conserved ser-thr dyad at residues 70-71. 29 ) In 
these cases mutants were recovered at the level of several mutants per 
thousand colonies. Though seemingly a low yield, this represents a few 
mutant colonies on each Petri dish and oligonucleotide screening at the 
DNA level is sufficiently rapid and reliable that at least several mutants 
can be easily recovered from each successful mutagenesis. (We have also 
obtained the fourth possible combination of serine-threonine residues in 
this region, (-ser70-ser71-); this protein shows a significant level of 
catalytic activity and was obtained by spontaneous mutation as discussed 
later.) 
5 
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8-Lactamase has recently proved a popular subject for studies of 
mutagenesis. In an elegant use of oligonucleotide directed mutagenesis, a 
primer was used to create a ser+arg substitution at the second position in 
the leader sequence. 30 In this "piggyback" procedure, the original tem-
plate had an ochre codon TAA at residue 4; the oligonucleotide primer cor-
rected this sequence to CAA (gl~), thereby allowing protein expression, 
and also introduced the mutation of ser+arg at the nearby site; at the 
same time a new Eco RI site was introduced in this region which facili-
tated screening for mutants. Another mutant of 8-lactamase, thiolacta-
mase, with a cysteine residue at position 70 was prepared by a specific 
reconstruction of the DNA sequence. 31 This approach depended on the loca-
tion of a restriction site in this region of the genome. In fact, the ser 
70+cys mutant has lost this restriction site, which was useful in identi-
fying mutants. The thiolactamase shows catalytic activity. 
As noted earlier, single-strand templates serve very effectively as 
subjects for oligonucleotide directed mutagenesis, and generally give a 
higher yield of mutants than do double-stranded plasmids. This approach 
has been used in creating a substitution mutant, with cysteine in place of 
serine, in the ATP binding site of tyrosyl tRNA synthetase. 19 This sub-
stitution was achieved by mutating the structural gene attached to Ml3 and 
was accompanied by an unusually efficient protein synthesis allowing easy 
isolation of the mutant protein. The major effect of the ser+cys substi-
tution was manifest in Km for binding ATP which was raised from 0.9 to 4.1 
mM; Vmax was reduced from 1.4 to 0.9 sec- 1 • 
Oligonucleotide directed mutagenesis has also been used to study 22 
the role of positively charged amino acids in the amino-terminal region of 
the outer membrane prolipoprotein of E. coli. Substitutions that reduce 
or eliminate the positive character of the amino terminus of the signal 
peptide substantially alter the processing and secretion of the prolipo-
protein. 
b. Segment Directed Mutagenesis - The techniques so far described focus 
on the creation of a mutant protein with a predetermined structure; such 
approaches are useful to learn the properties and functions of a protein 
with a prespecified structure. An alternate approach is to generate, by 
nonspecific mutagenesis, a large number of structural variants, to select 
those with particular properties and thus to determine the structures of 
those variants that manifest the desired properties. Such random muta-
genesis can be allowed to take place anywhere in the structural gene of 
interest or, to focus more closely on the role of a particular domain of 
the protein, can be restricted to a region, such as the leader sequence or 
a loop of a catalytic domain. 
Several methods are available to restrict the action of a non-spe-
cific mutagen to a particular segment of DNA. In general they depend on 
the in vitro generation of a single stranded gap or loop in the desired 
region ~double stranded DNA molecule, followed by a mutagenesis 
technique that operates only on single stranded DNA. 
i. Deletions Target a Region of DNA for Mutagenesis - To target a parti-
cular region of DNA for subsequent mutagenesis, deletion mutants have 
proved useful; they are relatively easy to obtain and have been extensive-
ly used in diverse genetic studies. In deletion loop mutagenesis 32 ' 33 the 
wild-type DNA and the deletion mutant DNA, both cloned in a bacterial 
plasmid in the same manner, are used to form circular heteroduplexes that 
contain a looped-out single stranded region of DNA from the wild-type 
6 
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strand; this looped-out single stranded region corresponds to the segment 
that was absent in the deletion mutant (see Fig. 2a). 
A gapped heteroduplex can also be constructed by annealing two 
linear molecules derived from the same plasmid if the shorter of the two 
is open at the site of the deletion. 3 ~ Again, the deletion defines the 
region of DNA to be mutagenized (see Fig. 2b). 
ii. Specific Nicks Target Regions of DNA for Mutagenesi£ - In a related 
approach, single strand gaps can be introduced into a double stranded DNA 
molecule (see Fig. 2c). In one procedure, the site is specified by a 
"nick" 35 ' 36 introduced at a site recognized by a specific restriction 
endonuclease. 37 An alternate approach used a single strand of a suitable 
restriction fragment in the presence of Rec A protein to generate a dis-
placement loop that is then susceptible to the action of 51 (single strand 
specific) nuclease 38 (see Fig. 2d). The "nick" introduced by these pro-




C. § Endonuclease OE•onucleaseo 
Eth1dium 
Brom1de 
d. Supercoiled ~ 




FIGURE 2: Specific segments of DNA can be made 
single st~ded in various ways. These single st~anded 
~egions then can be subjected to the action of a single 
st~and specific mutagen (a,b,c,d) o~ used to int~oduce 
mutations during in vit~o enzymatic DNA synthesis (b,a,d). 
a) Deletion loop 
b) Deletion gap 
a) Nicking at a specific site followed by gap expansion. 
d) Nicking in a specific ~egion followed by gap expansion. 
digestion with an exonuclease; 38 alternat~ly, specifically nicked mole-
cules can serve as substrates for nick translation. 3 ' 
After formation of single stranded gaps by the types of methods just 
discussed, a variety of techniques are available to mutagenize the single 
stranded regions. For example treatment with sodium bisulfite selectively 
converts cytosine to uracil residues in the single stranded DNA but leaves 
intact cytosine residues in the double stranded DNA. This procedure 
generates 8ingle or multiple G-C to A-T transitions. 
7 
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Procedures are also available for misincorporation of non-comple-
mentary nucleotide& during enzymatic repair of the single stranded re-
gion.~0'~1 For example, an error prone DNA polymerase has been used~ 1 to 
incorporate mismatched nucleotides at a specific site on the ~Xl74 genome. 
The site on the single strand phage template was specified by a restric-
tion fragment used to prime in vitro DNA synthesis. When the DNA sequence 
in the region of interest is~own, as in this case, base substitutions 
can be introduced at a particular site; the method can also be used to 
generate a "library" of mutations directed to a given region of the DNA 
template. 
One can also achieve misincorporation simply by omitting one of the 
four deoxynucleotide triphosphates normally present during enzymatic gap 
repair: under certain conditions, misincorporation of the three remaining 
nucleotides occurs at roughly equal frequency. Use of excess DNA ligase 
traps the misincorporated base. ~ 0 
a-Thionucleotides~ 2 .~ 3 have been shown to be incorporated into DNA 
in lieu of the normal nucleotides by DNA polymerase I of E. coli.~~ These 
thionucleotide analogues prevent normal proofreading during in vitro DNA 
synthesis with both E. coli DNA polymerase I and T4 DNA polymerase; 5 they 
also prevent digestion by E. coli exonuclease III. ~ 6 These analogues have 
also been used for misincorporation of non-complementary, excision resis-
tant bases into circular DNA molecules that contained single stranded gaps 
in specific regions. 
Both types of misincorporation reactions are reported to be effi-
cient. The nucleotide omission method, however, produces substitutions 
that are not predictable a priori and may introduce multiple base substi-
tutions when the single stranded segment of DNA being "misrepaired" is 
longer than a few bases. ~ 0 
Again, 8-lactamase has served as the subject of many of these ap-
proaches. Two different single stranded fragments of the DNA of the 8-
lactamase gene were used to direct the formation of D-loop structures in 
the presence of Rec A protein; 38 subsequent digestion with Sl nuclease 
produced single stranded nicks distributed throughout the length of the 
single stranded D-loops. The nicks were then enlarged to gaps and these 
then mutagenized with bisulfite and repaired enzymatically. Mutants were 
selected by screening for loss of ampicillin resistance; virtually all 
such mutants have base substitutions in the regions spanned by either one 
or the other of the two single stranded fragments used to direct muta-
genesis; they were a 369 base pair Taq I fragment that includes the ini-
tial 135 base pairs (45-N-terminal amino acids) of the 8-lactamase 
structural gene and a 128 base pair Pvui-Psti fragment from the center of 
the gene. 
c. Random Mutagenesis - The mutagenic strategies discussed above can be 
usefully c~mplemented by approaches involving random mutagenesis. For 
example, the construction of a catalytically inactive mutant enzyme by 
site-specific mutagenesis provides a unique opportunity to study the 
structural requirements for reactivity. 21 Such an inactive mutant, pro-
duced for example by a change in one of the residues at the active site 
that is essential for catalytic activity, can serve as a subject for 
testing what changes, if any, will lead to a restoration of activity. 
Such changes could either be at the active site itself or might, more 
interestingly, occur elsewhere in the protein in a fashion that compen-
sates for the original, inactivating mutation. Such compensatory sequence 
changes at a secondary site, should they be observed, would provide infer-
8 
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mation on residues that can play a key role in catalysis or in protein 
folding and may be distant, in terms of primary sequence, from the site of 
the original mutation. (The mutations at positions 211 and 175 of the a 
subunit of tryptophan synthetase constitute a well-known example of second 
site reversion: the substitution of glycine 211 by glutamate abolishes 
catalytic activity, but activity is restored by a tyrosine to cysteine 
mutation at position 175.) 47 
Such an approach has been applied to the double mutant of 6-lacta-
mase (ser 7~hr; thr 7l~ser)! 1 The normal level of misincorporation of 
bases, in the absence of techniques to enhance mutagenesis, in the repli-
cation of plasmid DNA in E. coli is of the order of 1/106 at any locus. 
Accordingly, one might expect to recover catalytically active revertants 
of an inactive double mutant that have changes at a single amino acid 
residue; changes in two or more sites are very much less likely; thus 
phenotypic screening for catalytically active revertants is unlikely to be 
overwhelmed by reversions to the original wild-type enzyme. When applied 
to the inactive double mutant of 6-lactamase, this procedure gave rise to 
an active revertant (thr7l~er) that had recovered the normal serine 
residue at 70, apparently essential for catalytic activity, but retained 
the mutant serine (in place of threonine) at residue 71. 
Random point mutations, both spontaneous and induced by mutagenic 
agents can be useful in identifying sites essential for function, and also 
for the isolation of large numbers of nonsense mutations as in the case of 
the lac repressor protein. 48 Random mutagenesis is also well suited to 
the generation of proteins with altered characteristics when selective 
pressures are applied to mutagenized populations of cells; this approach 
produced a mutant 6-lactamase with an increased affinity for cephalospor-
ins. 49 
d. Suppression of Nonsense Mutations - Nonsense mutations can be obtained 
in large numbers at many different sites or at a specific site or region 
by adaptation for this purpose of any one of a number of mutagenic strate-
gies, including any of those described above. Proteins with altered amino 
acid sequences can then be obtained when the mutant gene is expressed in 
an appropriate suppressor strain. 50 In this way a single amber mutant can 
be used to introduce different amino acid substitutions by using different 
suppressor strains. As an example of this approach, many mutants of the 
lac repressor protein have been produced•s-so and characterized 50 ' 51 
yielding important insights into the nature of protein-DNA interactions. 
Major Restructuring - Today's ability to manipulate the DNA of structural 
genes allows one not only to create proteins that are relatively minor 
variants of the parent; it also allows one to create almost totally 
redesigned structures. For example, to establish the relationship between 
structural domains and the contribution of these domains to function, 
various segments in the structural gene can be progressively deleted. Such 
an approach has been used 52 to delete from the structural gene for alanyl 
tRNA synthetase segments that code for the carboxyl terminal region of the 
protein. 
Another approach to the elimination of C terminal regions involved 
the use of chain terminating mutations; 53 ' 54 the objective in this case 
was to study the role of the carboxyterminus in the processing and secre-
tion of 8-lactamase into the periplasmic space. Drastic alteration in the 
sequence in a region of a protein, without altering the length of the 
polypeptide chain, has also been accomplished in this system by the intro-
duction of double frameshift mutations. 55 
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Other major restructurings involve use of recombinant techniques to 
produce fused or hybrid proteins so that, for example, the products of 
exogenous genes can be expressed, and even sometimes secreted, by bacte-
rial cells. Examples abound, but two involving S-lactamase may serve to 
illustrate the strategy. In one, the gene for rat proinsulin was fused to 
the gene for the leader sequence of S-lactamase with consequent transport 
of the proinsulin into the periplasmic space of E. coli. 56 ' 57 In a second 
example, the gene for S-lactamase, devoid of its-own leader sequence!
8
was 
fused to the leader sequence of ~-amylase from!· amyloliquefasiens; in 
consequence, S-lactamase from gram negative ~· coli was efficiently 
secreted by gram positive!· subtilis. 
Conclusion - As we hope this review demonstrates, many techniques have 
recently been developed that allow a variety of quite novel approaches to 
studies of the relationship between the linear sequence and the function 
of proteins. Much of the discussion has focused on procedures for mani-
pulating the DNA to achieve proteins with altered function. Largely 
because it is still early days, few specific cases have been discussed in 
which insights have been gained into the functional roles of particular 
structural domains, or even single residues of proteins. However, toward 
solution of these problems, the new methodologies allow, for the first 
time, a truly systematic approach; their application should now proceed 
rapidly and allow one to address such intriguing questions as: What are 
the essential structural features for a protein to function effectively as 
a catalyst, hormone, or receptor? How are the various structural aspects 
of an antibody related to its ability to distinguish self from non-self 
and thereby, for example, to initiate the destruction of infectious agents 
such as bacteria and viruses, or the altered cells that form tumors? What 
regions of a protein located on the surface of a cell carry the informa-
tion essential to the interactions between cells that play a central role 
in the development from a single cell (the fertilized egg) of a complex 
organism such as man? From these studies will come striking new insights 
into the mechanisms by which proteins successfully carry out their myriad 
functions as well as the ability to design proteins with specific, novel, 
and useful properties. 
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Since the publication of this review article, the ap-
plication of in vitro mutagenesis techniques to problems in 
enzymology has aquired momentum as researchers interested 
in the chemistry and biochemistry of proteins and peptides 
have realized the great potential benefits of applying the 
experimental tools of molecular biology to the study of 
diverse problems in protein biochemistry. 
The nature of the problems being investigated by site 
specific mutagenesis alone, ranges from studying the role 
of specific residues in catalysis, as in the case of tryp-
sin and chymotrypsin (59), dihydrofolate reductase (60), 
tyrosyl tRNA synthetase (19, 61), and beta lactamase (62, 
63, and this work), to the role of disulfide bridges in 
protein stability (60, 64, and this work), and the 
structural requirements for functional leader sequences in 
the secretion of proteins such as beta lactamase (65) and 
the outer membrane lipoprotein of E. coli (66). Until very 
recently these problems would have been approached by chem-
ically modifying specific residues, by determination of 
various physical and chemical properties and the applica-
tion of these same methods to the study of naturally occur-
ring variants or variants obtained by random mutagenesis. 
What the methods of specific in vitro mutagenesis add to 
the former approach are the necessary tools to carry out a 
systematic study of protein variants, introducing an ele-
ment of control which maximizes the effectivenes of physi-
12 
cal and chemical methods by allowing one to precisely sub-
stitute functional groups within a protein in a rational 
manner. 
The increasing efficiency with which long segments of 
DNA can be synthesized will make the construction of genes, 
rather than the cloning of natural genes for proteins of 
interest, the method of choice in many cases, since 
synthetic genes can be designed with restriction sites and 
structural features that facilitate the introduction of 
sequence changes as well as the expression of the gene 
products. This, as well as the many other applications of 
synthetic DNA in molecular biology, is another good example 
of one discipline, chemical synthesis in this case, provid-
ing a systematic solution to technical problems in another. 
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ABSTR.-\Cf We have used oligonucleotide-directed mutagen-
esis to make a specific change in the IJ-Iactamase (EC 3.5.2.6) 
(ampicillin resistance) gene of the plasmid pBR322. Evidence sug-
gests that the active site for this enzyme may include a serine-thre-
onine dyad (residues 70 and 71). By priming in dtro D\A synthesis 
with a chemically synthesized 16-base oligodeoxyribonucleotide, 
we have inverted the Ser-Thr dyad to Thr-Ser and thereby gen-
erated a mutant with an ampicillin-sensitive phenotype . This "dou-
ble-mismatch" method is relatively simple and also very general 
because detection of mutants is at the level of D\A and involves 
only colony hybridization. Accordingly, the procedure can be ap-
plied to any D\A sequence and does not depend on the phenotype 
of the mutant. 
Rational studv of the influence of amino acid sequence on the 
three-dimensional structure and function of a protein would 
benefit greatly from the abilit\· to change specific residues . 
\\'hen the gene for the protein has been cloned and is expressed 
in an appropriate vector , site-directed mutagenesis (1, 2) pro-
vides a method for creating new proteins whose structural and 
functional characteristics may be of practical value or may offer 
significant mechanistic insights . 
Oligonucleotide-directed mutagenesis . the most specific 
fonn of directed mutagenesis, has been used to produce specific 
base changes in the single-stranded phage d>Xl74 (3, 4\ The 
method (Fig. 1) involves priming in t:itro D!'\A synthesis Y.ith 
a chemically synthesized oligodeoxynucleotide that carries at 
least a single base mismatch Y.ith the complementary strand of 
the "wild-type" D!'\A. Because D!\A polymerases require a 
double-stranded segment for initiation of D\A replication. the 
synthetic oligodeoxynucleotide primes D\A synthesis and is , 
itself, incorporated into the resulting heteroduplex molecule . 
After molecular cloning, semiconser\'ative in t:it.:a replication 
of this heteroduplex gives rise to homoduplexes whose se-
quences are either that of the original wild-type D!'\A or that 
of the synthetic oligodeoxynucleotide. With single-stranded 
circular D!\As, priming Y..ith oligodeoxynucleotides has been 
used to cause transitions , transversions , and deletions , in some 
cases very efficiently (5-11). Wallace et al. (12. 13) have ex-
tended the technique to double-stranded circular D!\As, and 
even though the frequency of directed mutagenesis may be 
lower, screening of colonies with the 32P-labeled synthetic oli-
godeoxynucleotide allows easy detection of the desired mutant 
(12, 13). 
The particular virtue of oligonucleotide-directed mutagene-
sis for structure-function studies lies in allowing one to produce 
mutant proteins with very specific changes in particular resi-
The publication costs of this article were defrayed in part by page charge 
payment. This article must therefore be hereby marked "adt;erlise-
ment" in accordance "; th 18 U. S. C. § 17~ solely to indicate this fact . 
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dues. which, for example, may be directly involved in catalysis 
or in determining substrate specificity. In this way, one can test 
ideas about the roles of particular amino acid side chains . Other 
procedures are valuable for producing random or less specific 
changes as , for example, in the creation of a mutant of 1)-lac-
tamase (EC 3.5.2.6) with enhanced activity toward cephalospo-
rins (14). Interesting mutants of 1)-lactamase have also been 
generated by segment-directed mutagenesis (15. 16) or by mis-
repair of gaps placed at restriction sites (1 i ). 
1)-Lactamase provides a particularly favorable system for de-
veloping the technique of oligonucleotide-directed mutagenesis 
and for demonstrating the general feasibility of this approach 
to the studv of protein function . The gene for ,B-lactamase is 
contained in the common double-stranded cloning vehicle plas-
mid pBR322, which has a total of only 4,362 base pairs and which 
contains a second selectable marker for resistance to tetracY-
cline (18). The complete nucleotide sequence of the 1)-lactama~e 
gene has been determined (19), and when pBR322 is grO\m in 
Escherichia coli , the enzyme is expressed and secreted into the 
periplasmic space, from which it can be readily isolated (201. 
1)-Lactamase catalyzes the hydrolysis of the amide bond of 
the lactam ring of penicillins and related antibiotics; the catalytic 
pathway includes an acyl-enzyme intermediate (20l. A serine 
residue probably participates in catalysis (21-26) and is part of 
a conserwd Ser-Thr dyad (26l. [These residues have been num-
bered Ser-70 and Thr-71 (26). ) Presumably the hydroxyl group 
of Ser-70 adds nucleophilically to the carbonyl group of the .B-
lactam ring in a mechanism somewhat analogous to that of serine 
prot eases . The role of Thr-71 is less clear, but it seems essential 
for catalytic activity because a mutant, probably "'ith isoleucine 
at this position, shows no catalytic acti\'ity (261. 
In this work, whose main focus was on the procedures for 
generating and identifying site-specific mutants , we used a dou-
ble-mismatch method to invert the order of the d\'ad from Ser-
Thr to Thr-Ser (i.e ., a double mutation Ser-70 ....,.· Thr and Thr-
71....,. Ser). The mutant bacteria show no ,B-lactamase acti\'ity, 
which suggests a functional defect in the mutant enzyme. 
MATERL\LS ASD METHODS 
D~As and Transformation. Plasmid pBR322 (1 8) was gro\m 
in E. coli strain LSI (pro , leu , thi , rpsL20, hsdR , hsd.\1 . ara-14, 
ga/K2, ryl-5 , mtlA , sup£44 ), aderivativeofHBlOl (27 ). Plasmid 
D~A was prepared according to the method of Birnboim and 
Doly (281 and supercoils were further purified by chromatog-
raphy on acridine yellow ED gel (Boehringer ~1annheim l as 
Abbreviations ~aCI /EDH/Tris. 0.15 ~I ~aCI/1 m~l EDTA/0.03 M 
Tris·HCI , pH 8.0; ~aCI/Cit, 0.15 M ~aCI/0. 015 M sodium citrate, pH 
7.0. 
t Present address : Laboratoire de Chimie Organique, 1nstitut Pasteur, 
Paris. France. 
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described by Vincent and Goldstein (29) or, alternatively, by 
ethidium bromide centrifugation followed by gel filtration (30). 
It probably is important that the plasmid D~A be free of oli-
godeoxynucleotides that often contaminate Dl\'A preparations. 
For secondarv transformations, where in r.;itro Dl\'A S\'llthesis 
is not involved, the rapid plasmid Dl\'A isolation pr~dure of 
Ish-Horov.icz and Burke (31) is convenient . Competent cells 
were prepared and transformations were done according to 
Hanahan (32). Selection was for resistance to tetracycline at 20 
ILg/ml. 
The l~base oligodeOX)'tlucleotide 5' -A-A-T-G-A-T-G-A-C-
C-T-C-T-T-T-T-3' was synthesized from dinucleotides by the 
biester method on a solid-phase support (33). 
Enzymes. E. coli exonuclease III, E. coli DNA polymerase 
1 (large fragment}, phage T4 ligase, and the restriction enzyme 
Hpa II were obtained from Bethesda Research Laboratories. 
T4 pol}'llucleotide kinase was obtained from Boehringer ~ann­
heim. 
Preparation of Sided DSA. Fifteen micrograms of pure 
supercoiled pBR322 Dl\'.~ and 9.0 IJ.g of ethidium bromide in 
150 ~J-1 of20 m\f Tris·HCI, pH 7.4/1 m\f dithiothreitol/7 m\f 
MgCI2 were treated in the dark at room temperature with 7.5 
units of Hpa II for a time estimated to produce about 75'l nicked 
circles and 2511t linear molecules (about 1 hr). The time and 
concentrations should be determined empirically on a smaller 
SC4ile with the same reagents . The reaction was assayed by elec-
trophoresis on 1.2'l agarose in 40 m\f Tris acetate, pH 7.8/ 
10 m\f EDTA (conditions that separate linear, circular, and 
supercoiled Dl\'A molecules). We used Hpa II for nicking be-
cause 52 Hpa II sites are in pBR322 (one of them is near the Ser-
70 region). Moreover, Hpa II is appropriately inhibited by 
ethidium bromide, in contrast to some other restriction en-
zymes (e.g., Pst I). Dt\ase 1 could also have been used (13}, 
because the precise location of the nick probably is not critical. 
The reaction was stopped by adding 0.1 vol of 0.1 M EDTA 
and the solution was extracted twice with phenol, once with 
chloroform, and then twice with diethyl ether. These extrac-
tions removed both protein and ethidium bromide. The DNA 
was precipitated by adding 0.1 vol of 3 M ammonium acetate 
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with 70% (vol/vol) ethanol, dried, and dissolved in 15~-LI of ster-
ile water. 
Exonuclease Treatment, Heteroduplex Formation, and 
Transformation. About 1~-Lg (0 .4 pmol) of the nicked DI\A was 
treated for 15 min at room temperature with 6 units of E. coli 
exonuclease III in 50 m\f Tris·HCI, pH 8.0/5 m\f \fgCI,d10 
m\f 2-mercaptoethanol (total volume, 3 ~oLI) . The enzyme was 
inacti\'ated by heating to 6<rC in the presence of chloroform, 
which was then removed by evaporation under reduced pres-
sure. The nicked and exonuclease-treated DI\A was heated to 
65•c for 5 min in 0.5 \f 1\aCI in the presence of 80 ng of the 
synthetic oligonucleotide (18 pmol) in a 5-~J-1 volume and al-
lowed to stand at room temperature for 1 hr. 
Buffer and salt concentrations were adjusted to 100 m\f 
1\aCI, 20 m\f Tris·HCI at pH 7.5, 10 m\f dithiothreitol, 10 m\f 
MgCI2, each of the four deox}nucleoside triphosphates at about 
400 1-1-\f. and 500 1-'\f A TP. Sixteen units of E. coli Dl\A poly-
merase I Oarge fragment) and 40 units ofT4 Dl\A ligase were 
added to yield a final reaction volume of 50 ILl. Four microliters 
of this reaction mixture was used directly to transform com-
petent E. coli LS 1. A second cycle of transformation was usually 
done after a quick plasmid preparation (31 ) &om an overnight 
10-ml broth culture containing tetracycline at 20 1-'g/ml and 
inoculated with the original transformation mix. 
Colony Screening by Primer-Probe Hybridization. wrgen 
et aL (34) described a microliter dish colony collection proce-
dure and a procedure for making filter paper replicas of the 
colony collection . By follo"'ing this procedure, a colony collec-
tion was made, transferred to agar with a 96-prong replicator, 
and grov.n for 18 hr. The colonies were "lifted" onto Whatman 
541 filter paper for amplification on 251.J/ 1-'g/ml chloramphen-
icol plates for 24 hr, followed by alkali lysis and neutralization 
(34). The filters prepared in this way were then prehybridized 
for 3 hr at ss•c in 6x 1\aCI/EDTA(fris, 0.511i 1\onidet P-40, 
and denatured, sonicated salmon sperm Dl'\A at 100 1-'g/ml 
(1 x 1\aCI/EDTA/Tris is 0.15 M 1\aCl/1 m\f EDTA/0.03 ~f 
Tris·HCI, pH 8.0). Hybridization with 32P-labeled oligonucleo-
tide was done at room temperature for 16-18 hr in 6x NaCl/ 
EDTA(Tris, 0.5'! Nonidet P-40, 25IJ 1-'g of yeast tRNA per 
ml, and 1.6 ng of 32P-labeled oligodeoxynucleotide per ml (at 
21 
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Mu1CJ'l1 NHz • • • • met • - • j thr • Mr j • phe • • • • 
Promer 
C ,T, 
5'- A AT G AT G A' 'c C T T T T - 3' 
····TTACTACTCGTGAAAA···· ~ 
I I I 
405 410 415 nt NO 
Wild· Type NHz • • • • met • met • !oer tnr i • phe 
oo NO 
FIG. 2. Nucleotide sequence of the synthetic oligodeoxynucleotide 
used as a specific mutagen and of the complementary wild-type strand. 
The amino acids encoded by both mutant and wild-type sequences are 
shown. nt NO is the nucleotide number in pBR322 !19!. aa NO is the 
amino acid number in j3-lactamase 1261. 
least 107 cpm/ p.gl. The filters were washed three times in 25-
50 ml per filter of6 x ~aCI/Cit (1 x ~aCI/Cit is 0.15 \f ~aCI/ 
0.015 \1 sodium citrate. pH 7.0) for 5 min at room temperature 
and autoradiographed . The temperature of the hybridization 
and washing is important and will \'ary with the nucleotide se-
quence and length . We ha,·e followed empirical rules de,·el-
oped by Suggs et al. (35) for oligodeoxynucleotide hybridizations 
on Southern blots and colony screens. One estimates the ap-
parent melting point (tdl to be the sum of 2°C per A·T base pair 
and 4°C for each G·C base pair when the hybridizations and 
washes are done in 6X ~aCI/EDTA/Tris or 6x l'aCI/Cit . \\'e 
do the hybridizations at least 5°C below the calculated td and 
do a series of washes and autoradiography, first at 5°C and then 
at higher temperatures to ensure passing through the temper-
ature that best distinguishes mutant from wild type . 
RESl'LTS 
Fig. 1 illustrates our use of a 16-base synthetic oligodeoxvnu-
cleotide with two deliberate base pair mismatches to prime in 
22 
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vitro D!\A synthesis on pBR322 D\A containing single-
stranded regions that had been generated by exonuclease treat-
ment of nicked, double-stranded circles. The two mismatches 
in the primer d(A-.4.-T-G-A-T-G-A-C-C-T-C-T-T-T-Tl at the bases 
denoted (*) will accomplish the double mutation Ser-iO-+ Thr 
and Thr-71-+ Ser (Fig. 2). For generality, the method is de-
signed for screening at the D!\A level rather than depending 
on the phenotype of the mutant protein . Therefore , we haYe 
used colony hybridization .,..;th a 32 P-labeled oligodeoxYnucleo-
tide to select mutants . Conveniently. the same oligodeox\·nu-
cleotide used as a primer in the in t:itro synthesis can be labeled 
with 32P and also used as a hybridization probe. Those colonies 
containing the mutant gene will match perfectly .,..;th the sYn-
thetic probe and therefore hybridize more stronglY than will 
.,..;ld-type colonies, which have two base pair mismatches. 
Fig. 3 shows the result of a colon\ screen; a mutant can be 
clearly identified . In this experiment, colonies were picked and 
distributed into microliter dishes to provide an ordered arraY 
and a permanent librarY (34). After growth. a filter replica of 
the colonies was made and used for colony screening ( 13. 34 l. 
The microliter dish technique allowed convenient screening 
of a few thousand colonies and was used to isolate the first mu-
tant (22G9). However, when it became apparent that the fre-
quency of the desired mutation was only about one in a thou-
sand. we began to use a random colony screening procedure . 
which allows the rapid evaluation of tens of thousands of colo-
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a control with random colonies of a known perfect match (mu-
tant 22G9l. the top shows a similar screening of about 1.800 
colonies resulting from an independent in dtro mutagenesis 
experiment . Wild-type colonies do giw a weak signal. but mu-
tants. two of which can be seen . stand out clear h-. The back-
ground and positive signal is somewhat \'ariable . ·and , for this 
reason. oligodeoxynucleotides of at least 15 bases probably 
should be used for this type of screening. e,·en though shorter 
oligodeoxynucleotides rna\ serw for the priming step and for 
Southern blotting (7. 8). A 19-base probe gives a ,·ery strong and 
reliable signal (13) Differences of two bases between mutant 
and wild-type greatly increase the ability to identif,· mutants 
unambiguously, e\·en though , in most cases, single-base mis-
matches probably can be identified (131. 
E'en with the double-mismatch method used in this work. 
false positi,·es occasionally were observed, especially when 
unordered colonies were screened. Random dark spots, prob-
abl' from [ 32P]ATP or [ 32 P]orthophosphate. also occur and often 
cannot be clearly distinguished from mutant colonies. The num-
ber of these spots can be reduced significantly by filtering the 
solution for hybridization just before use ; nevertheless , a second 
screening of plasmid D!'\A from a putati,·e mutant is essential 
Fortunate], , this can be ac-complished easih b,· a rapid prep-
aration of D\A (31 l followed by agarose gel electrophoresis and 
hybridization (36). The standard Southern transfer to nitrocel-
lulose (361 can be used, but we ha'e found it even more con-
venient to simply dry the agarose gel and use the resulting agar-
ose membrane directh for hvbridization with the 32 P-labeled 
oligodeoxynucleotide (S. G. s·. Tsao. C. F. Brunk, and R. Pearl-
man ; personal communication ). Fig. 5 illustrates the unambig-
uous discrimination between wild-type and mutant colonies. 
This analysis also discriminates single base mismatches (ref. 13 
and unpublished data) and should show differences between 
single- and double-base mismatches, possibly because anY such 
mutants were not picked at the earlier colony screening step 
25 
(the faint colonv in Fig. 3 has not yet been analyzed ). 
To show that the expected two-base change has actually been 
made. the sequence of the D\A in the region of the active site 
(Ser-70 and Thr-7ll has been determined b\· the \taxam-Gilbert 
technique (37) and the sequence in one ~trand has been con-
firmed by the dideoxy method (38) after subcloning in \t 13mp7. 
Although mutant colonies can be identified by colony h\-
bridization after the first transformation with heteroduplex plas-
mid D\A. these colonies probably contain a mixture of wild-
type and mutant plasmids because the colonies grow in ampi-
cillin . Mter a rapid preparation of plasmid from these ''mixed '" 
colonies and a second ·transformation , 30-50'k of the resulting 
colonies hvbridize strongly to the 32P-Iabeled oligodeoxynu-
deotide. all of these are sensiti\·e to ampicillin . 
\\'e han' obtained mutants in three independent repetitions 
of the procedure. All show similar characteristics of hvbridiza-
tion and ampicillin sensiti\·ity. Sewral thousand apparent]\ 
wild-type colonies also were screened and all of these were re-
sistant to ampicillin . Thus, the procedure does not produce. at 
a detectable frequency. random mutants that have functionall\· 
inactiw ,8-lactamase. A fortuitous connection between the dem-
onstrated D\A sequence changes in the mutants and the am -
picillin-sensiti\e phenotype seems remote. 
DISCt:SSIO~ 
The procedure described here reproducibly yields mutants that 
hybridize much more strong], than wild-t~ ·pe colonies with the 
synthetic oligodeox\·nucleotide probe that is used first as the 
primer for in ritro synthesis of heteroduplex plasmid and then 
as a probe for identif\·ing mutants . The plasmid D\A of one 
mutant has been characterized in the region of the mutation and 
shown to ha\e the desired sequence . 
All of the mutants that show strong hybridization with the 
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of Ser-Thr to Thr-Ser was expected to affect catalytic acti1·ity 
because. for example. the substitution of the primary alcohol 
ofSer-70 by the secondary akohol ofThr might sterically hinder 
nucleophilic attack bv the hydroxyl group: the amino acid 
changes also might cause conformational rearrangement within 
the acti1 e site. Particularly interesting in this respect will be 
studies on the ability of the mutant protein to bind penicillins 
and related substrates . as distinct from its abilitv to act as a cata-
lyst. Also of interest will be the effects of the single changes Ser-
70-+ Thr and Thr-71-+ Ser. These mutants might have arisen 
by partial repair during the mutagenesis procedure. but so far 
we haw isolated no such single-base-change mutants Although 
preliminary studies on cell extracts suggest that the mutant 
protein is catalytically inacti1 e. other reasons for the absence 
of ampicillin resistance . such as more rapid proteolytic degra-
dation of the mutant protein. remain a formal possibility. 
The present 1 ield of mutants. about one per thousand, should 
be raised significantly b1 further impro1 ements. Howe1 er. a 
major point is that impro1 ements are not required because of 
the rapidit1 and reliabilitl of the screening procedure (13 ) The 
screening procedure depends on],· on D\:\ sequence and not 
on an1 phenot1-pic difference between mutant and wild t1·pe. 
This feature allows easY detection of mutants e1·en with phe-
not,·picalh silent changes . For example. e1·en though the Ser-
iO-+ Thr and Thr-71-+ Ser mutant of 13-lactamase created in 
this work is functionallY inacti1 e. one could as easih ha1·e iden-
tified a mutant that r~tains normal acti1·ity. has ~cquired en-
hanced catalytic effecti1 eness . or dispJa,·s altered specificities 
for 1 arious substrates. The use of double-base mismatches to 
facilitate identification of mutants. e1 en when one of these base 
changes causes no amino acid change. should be emphasized. 
The degeneracy of the genetic code makes the double-mismatch 
approach applicable e1 en for sing!!:' amino acid changes. Tht':'se 
ft':'atures of the method. together with the abilit1· to crt':'ate spt':'-
cific mutations at any region of the genom!:'. should encourage 
its widt':'spread application. 
The generation of a specificallY restructured mutant protein 
generallv will require six steps (i l cloning of the rele1 ant gene 
in an appropriate 1ector. (ii 1 expression of the clont':'d gene, (iii ) 
determination of the D\:\ sequenct':' of tht':' gene. (ir ) chemical 
s1·nthesis of an oligodeoxynucleotide. tr l oligonucleotide-di-
rt':'cted in ritro mutagenesis . and tt: il identification of mutant 
colonies. This work has focused on steps r and t:i, which . to-
gether with present and rapidly impro1 ing techniques for ac-
complishing steps i-it:, should allow the restructuring of pro-
teins to become a common undertaking and thereby increase 
our understanding of the relationship between primary struc-
ture and biological function . \lore01·er, such techniques also 
will allo11 the s1·nthesis of new proteins 11ith useful properties 
not hitherto a1·ailable. 
\ote Added in Proof. L'sin~ this technique, we have generated a one-
base mutant. Ser-iO -+ Thr [di ... A-T-G-A-T-G-A-C-C-A-C-T . . I] . 
which i~ catalvtically inactive. \\'e ha1e also obtained Thr-71-+ Ser 
[di .. A-T-G-... ·T-G-A-G-C-T-C-T .. )]. which has a low level ofacti\'ity 
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CHAPTER II 
SITE SPECIFIC MUTAGENESIS METHODS 
SPECIFIC SINGLE BASE SUBSTITUTIONS GENERATE 




Specific Single Base Substitutions Generate 
Three Variants of Beta-Lactamase: 
ser70-->thr, ser70-->arg 
and cys77-->ser 
Two additional site specific mutations have been ob-
tained at the active site of beta-lactamase by oligonucleo-
tide directed mutagenesis in the double stranded plasmid 
pBR322 using exonucleased nicked DNA as a template, and a 
third one at another site using an Ml3 vector as a 
template. The mutations were designed to introduce 
threonine and arginine at position 70 and to remove one of 
the only two cysteines in the enzyme (cys 77), replacing it 
with serine, thereby removing the single disulfide bridge. 
In this Chapter, the construction of these three mutations 
will be described and the reasons for introducing the 
mutation ser 70-->arg will be discussed, but the changes 
ser70-->thr and cys 77-->ser will be discussed in detail in 
Chapter IV. Table I summarizes the changes that I have 
obtained in the active site region of beta-lactamase, and 
the oligonucleotides used to introduce them. 
Ser70-->tbr 
The construction of the sequences -thr70-ser71- (Chapter 
I),-ser70-ser71-(Chapter III), and -thr70-thr71- was 
designed to shed light on the catalytic mechanism of beta-
32 
lactamase and this will be discussed in Chapter IV. 
Ser70-->arg 
The sequence change to arg 70 was designed for other 
purposes, although based on existing knowledge of the cata-
lytic machanism of the enzyme. (This is a project done in 
collaboration with Patricia L. Foster and David Botstein.) 
It has been shown recently that some powerful carcinogens 
have as a common feature the ability to introduce G-C to 
T-A transversions (1,2). Whereas there are methods of iden-
tifying the mutagenic specificity of chemical mutagens by 
using the genetic system developed by Miller et. al. (3), 
it would be advantageous to have a simple direct assay to 
detect specific, induced base substitutions. Developing a 
tester strain for G-C to T-A transversions, for example, 
would allow the identification of other mutagens that 
induce this type of base change; it would also allow one to 
select for bacterial mutations that specifically affect the 
induction of G-C to T-A transversions, thereby helping 
understand the nature of the primary DNA lesion(s), and DNA 
repair events that lead to a particular type of base 
substitution. In principle tester strains could be con-
structed as described below, to assay for every kind of 
base change. Such an assay should have the following pro-
perties: (a) the induced mutations must give a dominant 
selectable phenotype, and (b) only the desired base change 
33 
TABLE I 
MUTATIONS AT THE ACTIVE SITE 





















































































































































































































































































































must be able to produce the phenotype. 
Organisms carrying the gene for beta-lactarnase are 
resistant to penicillins and related antibiotics by virtue 
of the enzyme's catalytic activity which causes the hydro 
lysis of beta-lactams. Catalysis is brought about by a nu-
cleophilic attack of the active site serine hydroxyl (4) 
group on the carbonyl carbon of the beta-lactam ring of 
penicillins and cephalosporins which results in the forma-
tion of an acyl-enzyme intermediate (5). The only aminoacid 
substitution at position 70 of beta lactamase known to pro-
duce an active enzyme is ser-->cys (6); with this in mind 
it seemed virtually certain that introducing arginine at 
that position would produce an inactive enzyme. 
Serine is encoded by the codons TCN and AGCjT, and 
arginine by CGN and AGA/G. The serine at position 70 of 
beta-lactamase is encoded by AGC, which can be specifically 
mutated to CGC by a single base change. Bacteria carrying 
this mutant beta-lactamase gene could revert to ampicillin 
resistance by a single G-C to T-A transversion, which would 
generate a serine codon at position 70. The codons for cys-
teine are TGT/c so a single C-G to T-A transition could 
give rise to a cysteine codon at position 70 of 
beta-lactarnase; however, the cysteine enzyme which is known 
to be active is inhibited by PCMB (6) so it can be clearly 
distinguished from the serine enzyme that would be produced 
by a G-C to T-A transversion. In addition, the serine 
36 
enzyme is inhibited by borate, whereas the cysteine enzyme 
isnot (7). 
Figure II-1 summarizes the possible aminoacid substitu-
tions that can occur by a single base change. None of the 
other aminoacid substitutions resulting from a single base 
change of any kind (leucine, proline, and histidine) would 
produce an active beta-lactamase. Therefore a strain carry-
ing the beta-lactamase mutation ser->arg could be used to 
identify potential carcinogens capable of producing GC to 
TA transversions, by comparing the spontaneous rate of 
reversion to ampicillin resistance to the rate of reversion 
found in the presence of a given chemical. 
Site specific mutagenesis is the ideal tool to develop 
this tester strain and I have obtained the mutation as 
described below; Patricia L. Foster is in the process of 
characterizing the strain and developing the assay for 
carcinogens. 
Cys77-->ser 
The E. coli beta lactamase has a single disulfide bond 
between cys77 and cysl23 (8) which can only be reduced in 
conditions that also denature the protein. The mutation cys 
77-->ser77 removes one of the two cysteines present in ma-
ture beta-lactamase, thus eliminating the possibility of 
forming this disulfide bond. Doing so enables one to study 
the effect of its absence on the secretion and processing 
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FIGURE II-1 
Mutations that can arise by a single base substitution in 








































































































































































































of the protein and the effect on the stability of the ma-
ture enzyme. 
The two active site mutations ( ser70-->arg and 
ser70-->thr ) were constructed using nicked, exonucleased 
pBR322 as a template, whereas cys77-->ser was done on a 
fragment of the beta-lactamase gene subcloned into Ml3rnp8 
( 9) • 
Oligonucleotide-directed mutagenesis Methods 
Site specific mutations can be obtained in genes cloned 
into either single or double stranded vectors by incor-
porating a synthetic oligonucleotide with the desired base 
changes. Several different strategies have been used suc-
cessfully in both types of vector, and so the advantages 
and disadvantages of each method should be considered in 
relationship to each individual case. Figure II-2 illus-
trates the mutagenic strategies that apply in each case. 
Oligonucleotide-directed mutagenesis can be used to ob-
tain single (Eg., 10), double (11), and multiple (12) 
specific base substitutions, as well as deletions and 
insertions (13) of one or more bases. The following is a 
description of how to design and obtain a site-specific 
mutation by oligonucleotide-directed mutagenesis. 
Sections (a) through (e) refer to mutagenesis on DNA 
cloned into a single or a double stranded vector; step (b) 
40 
FIGURE II-2 
A schematic outline of different experimental strategies 
for oligonucleotide-directed mutagenesis using: 
a) nicked and exonucleased plasmid DNA, 
b) linearized and exonucleased plasmid DNA, or 


















































































































is carried out by nature when a single stranded vector such 
as Ml3 is used. In the interest of clarity, Ml3 mutagenesis 
methods will be summarized at the end of this Methods 
section. 
a. The oligonucleotide 
characterization. 
design, synthesis and 
b. Obtaining the template • 
c. Repair reaction : enzymatic polymerization and ligation. 
d. Transformation. 
e. Screening. 
a. Oligonucleotide design, synthesis and characterization. 
!.Length. 
The minimum oligonucleotide length required for reliable 
screening is about fifteen bases. Shorter oligomers (six or 
seven bases) would function adequately as primers (14) if 
only a single base substitution were being introduced, but 
the binding specificity would be much lower and the 
signal-to-noise ratio in screening would be poor. Fifteen 
base oligomers can be used for single and double base sub-
stitutions, insertions and deletions. However, the length 
should be increased to obtain more complex mutations. Dele-
tions of several hundred base pairs have been obtained re-
cently using oligomers 17, 21, and 25 bases long; the best 
results were obtained with the longer oligomers (John 
Rossi, personal communication, 1983). 
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2. Sequence. 
The site and nature of the specific mutation to be in-
troduced determine the sequence of the oligomer. However, 
some precautions are necessary to reduce the possibility of 
unintended mutations. A homology search on both strands of 
the DNA to be mutagenized is necessary to avoid oligomer 
sequences that would anneal with high specificity at sites 
other than the one chosen for the mutation. Sites on the 
vector are as important as sites in the cloned gene, there-
fore the choice of vector is not trivial. Whenever possi-
ble, a small vector of known sequence should be used. 
If complete sequence information on the cloned gene to 
be mutagenized is not available, then it is preferable to 
subclone a smaller fragment whose sequence is known, for 
mutagenesis. 
The sequence of the oligomer itself should be examined 
for self-complementary regions, which should always be 
avoided. If either of these problems (homology or self-com-
plementary sequences) appear unavoidable, other vectors or 
other mutagenic strategies should be considered. 
When the purpose of mutagenesis is to obtain mutant pro-
teins, there are more alternatives than when the desired 
final product is a nucleic acid. The degeneracy of the 
genetic code can be used to advantage in designing muta-
tions in proteins. For example, a single aminoacid substi-
tution can be obtained using an oligonucleotide that in-
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troduces two base substitutions. This makes screening for 
mutants easier, because the difference in oligomer hybridi-
zation to mutant as compared to wild-type colonies is 
greater. It is not necessary to do this, but it can be 
helpful. 
3. Synthesis. 
Rapid, solid-phase methods for synthesizing DNA oligo-
mers using either the phosphotriester (15) or the phos-
phoramidite chemistry (16) have been recently developed 
either method is adequate, and both can and have been 
automated. 
4. Characterization. 
It is important to determine the purity of the oligonu-
cleotide after synthesis. The major impurities found will 
be shorter oligomers, which occur to a varying extent 
depending on the methods of synthesis and purification. 
This can be checked easily by electrophoresis on 20% po-
lyacrylamide, 40% urea gels. If impurities are present, 
they can be removed either by HPLC or by preparative gel 
electrophoresis. 
If desired, the ability of the oligonucleotide to bind 
specifically at the selected site can be checked by hybrid-
ization to a restriction digest, or by priming in vitro DNA 
synthesis on the appropriate template and looking for a DNA 
strand of specific length after restriction. Alternatively, 
the oligonucleotide can be used to prime dideoxy sequencing 
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reactions to confirm that it is priming specifically at the 
desired site. 
The sequence of the oligonucleotide can be checked by 
the Maxam and Gilbert method. 
b. Obtaining the template. 
In double stranded plasmids, the template for in vitro 
DNA synthesis can be obtained in either of two ways. In one 
case, the template is a partially single stranded circle 
obtained by nicking supercoiled DNA and treating it with an 
exonuclease (Figure II-2, a) and in another case, it is 
linearized and partially exonucleased plasmid DNA (Figure 
II-2, b). 
Nicked circles are obtained by digesting supercoiled 
plasmid DNA with an endonuclease in the presence of ethidi-
um bromide (17); under certain conditions, most of the DNA 
can be converted to nicked circles. The enzymatic nicking 
reaction is simple , but a series of pilot reactions should 
be done before attempting it on a preparative scale. The 
products of the reaction vary, depending on the relative 
concentrations of supercoiled DNA, enzyme, and ethidium 
bromide present initially. Temperature and length of incu-
bation are also important. In addition, the optimal condi-
tions for nicking are different when different restriction 
enzymes are used, and contaminants such as linear DNA can 
interfere by altering the effective ethidium bromide 
concentration. 
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The pilot reactions can be done using 1 to 2 units of a 
restriction endonuclease for each microgram of supercoiled 
DNA. The DNA concentration can be kept constant at about 30 
to 40 micrograms/ml, and the ethidium bromide concentration 
varied between .01 and .10 mg/ml. The reactions should be 
stopped quickly after an hour at room temperature by ex-
tracting with phenol and chloroform. 
The reaction products can be analyzed by gel electro-
phoresis on 1.2% agarose in 0.04 M Tris-acetate (pH 8.0) 
buffer; the supercoiled, linear and open circular forms of 
plasmid DNA are clearly resolved. It is possible to obtain 
more than 90% nicking, while eliminating virtually all of 
the supercoiled DNA. 
After the optimal conditions are determined, the reac-
tion can be carried out on a preparative scale. It is im-
portant that all the concentrations in the preparative 
reaction as well as the temperature and length of incuba-
tion are the same as in the pilot reaction. Phenol chloro-
form extraction (twice) stops the reaction and removes the 
ethidium bromide. The DNA is ready to use in the next reac-
tion after precipitating and washing with ethanol. If 
several mutations are to be introduced in the same plasmid, 
it is convenient to prepare a large amount of nicked DNA at 
one time. Two hundred to three hundred micrograms is an 
ample supply. 
In this case the template for in vitro DNA synthesis 
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FIGURE II-3 
Action of E. coli exonuclease III 
a) on linear, double stranded DNA, and 




















































































































































primed by the mutagenic oligomer can be obtained by digest-
ing 5 micrograms of nicked plasmid for fifteen minutes at 
room temperature with 30 units of E. coli exonucleaseiii in 
a 50 microliter volume, in the appropriate buffer 
conditions. The reaction should be stopped by adding a 
small amount of chloroform and heating to 65oc for ten 
minutes. It is important to destroy the exonuclease activi-
ty to prevent further digestion of the template and diges-
tion of the oligonucleotide in the following step of this 
procedure. 
Presumably at this point, some fraction of the modified 
plasmid molecules now have single stranded regions which 
span the site of the desired mutation (Figure II-3). The 
extent of the exonuclease digestion has not been determined 
quantitatively in this work, and it is possible that some 
or all of the intact circular molecules are completely sin-
gle stranded. However, I should emphasize that a partial 
digestion is preferable for two reasons: 
(a) In order to prevent, or reduce in vivo repair of the 
mismatch (9, 18), it is necessary to extend the 3' end of 
the primer, and to ligate its 5' end to the 3' end of the 
repaired strand. This can be accomplished either by com-
pletely resynthesizing the strand primed by the oligonu-
cleotide, on a completely single stranded circular tem-
plate, or by "filling in" the gaps between the oligonucleo-
tide primer and double stranded regions of the template. 
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The la~ter is easier to accomplish, since in actual prac-
tice it is sometimes problematic to extend a strand of DNA 
in vitro over a span of several thousand nucleotides. 
(b) The plasmid nicked in the presence of ethidium 
bromide may contain more than one nick per open circular 
molecule. If one or more nicks are present on both strands, 
complete digestion with exonuclease III will render these 
molecules useless as templates for in vitro DNA synthesis. 
Some evidence for the presence of at least one nick in each 
strand comes from alkaline gel electrophoresis (19) of the 
nicked DNA: it appears that much more than one-half of the 
DNA runs as a single stranded linear monomer of the 
plasmid. 
If the exonuclease treatment is only partial, then even 
molecules with multiple nicks could be repaired during en-
zymatic DNA synthesis as long as the circular nature of the 
molecule is preserved, thus improving the yield of 
molecules capable of serving as templates for the mutagenic 
oligomer. 
In the second method of obtaining a template, the 
plasmid is linearized with a restriction enzyme that cuts 
the vector DNA near the cloned DNA (20); the distance 
between this restriction site and the site to be mutated 
should be less than one-half the entire length of the 
plasmid. Depending on the position of this restriction site 
relative to the cloned DNA, the mutagenic oligomer should 
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be complementary to either one or the other strand. After 
the DNA is linearized, it is partially digested with E. 
coli exonuclease III . The extent of digestion should be 
sufficient to expose the site of the intended mutation, but 
not so extensive as to eliminate a region of double strand-
ed DNA that holds both strands together. 
It is convenient to determine the best digestion condi-
tions by treating aliquots of the linearized plasmid with 
varying amounts of exonuclease III. After stopping the en-
zymatic reaction by adding EDTA, the digests can be 
analyzed by gel electrophoresis on 1.2% agarose; if this 
gel is dried without heat or any other treatment, the sam-
ples that have been sufficiently digested can be identified 
by hybridization of the labeled mutagenic oligonucleotide 
to the resulting membrane. The oligonucleotide binds to 
single stranded regions of the DNA but not to regions that 
have remained double stranded. The remaining amount of the 
appropriate digest can then be used as template in the fol-
lowing reaction. 
In the third case (Fig II-2 c), template for mutagenesis 
is obtained by subcloning an appropriate fragment of the 
gene of interest into a single stranded vector such as one 
of the Ml3 cloning vectors and preparing single stranded 
phage DNA by standard procedures (9). 
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c. Repair Reaction: polymerization and ligation. 
Annealing of the primer and template .is done by combin-
ing a fifty to one hundred fold molar excess of the 
synthetic oligonucleotide with 1 to 5 micrograms of exonu-
cleased material from the previous reaction. They are heat-
ed to 65°C for one to five minutes, in a 5 microliter 
volume in either lOmM Tris-HCl pH 7.5, 0.5 M NaCl or lOmM 
Tris-HCl pH 7.5 0.2 M NaCl, 10 mM MgC12 , and allowed to 
remain at room temperature for 45 minutes. Alternatively 
they can be incubated at 37oc for 45 minutes to avoid the 
possibility of denaturing the template DNA . Then the rest 
of the substrates for the repair reaction are added in an 
appropriate buffer such that the final concentrations are 
0.5 mM each of the four deoxynucleotide triphosphates and 
ATP, 100 mM NaCl, 10 mM MgCl2, 20 roM Tris-HCl pH 7.5, 10 mM 
OTT (dithiothreitol), and the final volume is 50 
microliters. E. coli DNA polymerase (8 units, Klenow 
fragment, Boehringer-Mannheim) and T4 DNA ligase (400 
units, as defined by the supplier, New England Biolabs) are 
added last. If the oligonucleotide used in this reaction is 
labeled with 32p, its incorporation into the repaired 
plasmid can be monitored. After incubation at 25oc for 30 
minutes and at 15oc for at least 4 hours, the repaired DNA 
can be purified by extraction with phenol and chloroform, 
followed by ethanol precipitation.An aliquot of the 
redissolved DNA is then used for transformation. 
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Specificity can be improved by carrying out the repair 
reaction at 37oc if the Td is 42oc or higher; this prevents 
the oligonucleotide from binding at lower affinity sites, 
and it also helps reduce the formation of secondary 
structures on the template. 
d. Transformation 
When using Ml3 vectors, the standard transformation 
described by J. Messing (9) is appropriate. 
If the template was prepared from a double stranded vec-
tor the procedure described by Hanahan (21) is the most 
appropriate because of its high efficiency at low DNA con-
centrations which allows one to screen as many independent 
transformants as necessary. Since the frequency at which 
mutations are introduced can be low in some cases , it is 
often necessary to screen several thousand independent 
transformants to have a high probability of finding a clone 
carrying the desired mutation. Frequencies range from 5% to 
10% to as much as 40% for simple base substitutions on a 
single stranded phage template , or on a linearized double 
stranded plasmid template, but can be as low as one in one 
thousand when using exonucleased nicked circles as a tern-
plate; for large deletions,it can be as low as one in ten 
thousand (John Rossi, personal communication, 1983). 
For double stranded vectors, after transforming with the 
repaired DNA and ascertaining that a sufficient number of 
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independent transformants have been obtained, the transfor-
mation mixture can be used to inoculate a 5 ml broth 
culture. Plasmid DNA is prepared (22) and used in a second 
transformation in order to segregate the mutant and wild 
type aleles. The resulting transformants can be plated at 
an appropriate cell density for colony screening. It is 
possible to screen for mutants before segregating wild type 
and mutant plasmids, but the signal obtained when screening 
mixed genotype cells is not as clear, particularly for 
single base changes. 
With Ml3 vectors one can plate the transformants and 
either make filter replicas for screening or pick indivi-
dual plaques into broth cultures for dot blots, as 
described below. 
e. Screening 
When an adequate number of independent transformants 
have been obtained and plated at an appropriate cell densi-
ty, filter replicas can be prepared either on Whatman 541 
filter paper or on nitrocellulose as described in the 
literature (23) and in Chapter I. The synthetic oligonu-
cleotide used to direct mutagenesis is now phosphorylated 
with gamma- 32P-ATP and polynucleotide kinase, and used as 
a hybridization probe. 
Whatman 541 filter replicas are first prehybridized for 
two hours in 6X SET, 0.5% NP-40 (Sigma), 100 ug/ml 
55 
deproteinized, denatured salmon sperm DNA, lmM sodium 
orthophosphate, lmM sodium pyrophosphate, O.SmM ATP at 65oc 
for two hours. The filters are then hybridized for two 
hours at room temperature in 6X SET, 0.5% NP40, 250 ug/ml 
deproteinized yeast tRNA, lmM sodium orthophosphate, lmM 
sodium pyrophosphate, 0.5 mMATP, and 2 to 4 pmoles/ml of 
labeled oligonucleotide, filtered through a 0.2 micron 
filter immediately before using. Washing is done in 6X SSC~ 
first at room temperature (3 times for 5 minutes each time) 
and an autoradiogram is made. Additional washes are done at 
higher temperatures, beginning at 5 degrees below the 
estimated Td for the oligomer, taking autoradiograms after 
each wash. 
Any positives found are confirmed by picking and re-
screening at the colony hybridization level, and subse-
quently by hybridization to the purified plasmid or phage 
DNA, as well as by DNA sequencing. 
Mutagenesis in Ml3 Vectors 
An alternative to the mutagenesis method described for 
double-stranded DNA is to subclone the gene of interest or 
an apropriate fragment into an Ml3 vector. Single stranded 
template DNA is then obtained by the standard methods used 
to prepare template for sequencing with chain terminating 
inhibitors. 
Annealing and in vitro DNA repair is done essentially as 
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described for double-stranded vectors. There is evidence 
(24, 25) that the complete synthesis of a second strand of 
DNA primed by an oligonucleotide, using the circular, sin-
gle stranded viral template is not always efficient. This 
means that the 5' end of the mutagenic oligomer is not li-
gated, and any mismatched bases are more accessible to in 
vivo repair mechanisms, which results in few or no mutants. 
This difficulty can be circumvented by using the univer-
sal Ml3 sequencing primer to "extend" the 5' end of the 
mutagenic oligomer (9). If both the mutagenic primer and 
the universal Ml3 primer are annealed to the phage tern-
plate, extended by the action of DNA polymerase and ligat-
ed, the gap between the two is filled in, thus "sealing" 
the 5 1 end of the mutagenic oligomer and reducing the 
chance of in vivo mismatch repair in molecules that are 
incompletely synthesized in vitro. 
Some authors advocate separating covalently closed cir-
cular molecules from totally and partially single stranded 
molecules by sucrose gradient centrifugation (24). However, 
this seems unnecessary because even if few mutations are 
introduced, many phage-infected colonies can be screened by 
hybridization to filter replicas. Furthermore, if the 
desired mutation entails an improbable molecular event 
(e.g. a very large deletion), it might be difficult to ob-
tain enough ccc DNA to purify without doing unnecessary 
additional work. 
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The procedure for mutagenesis on Ml3 is described 
below. 
Procedure: 
The methods for growth of phage, and purification of 
phage DNA or RF DNA for sequencing, mutagenesis and cloning 
are described in detail by Joachim Messing in Methods in 
Enzymology, 101:20, 1983. 
Oligonucleotide design and char~cterization is essen-
tially as described in the previous section, although in 
searching for homologies between primer and template one 
need only consider the plus strand of the phage vector and 
the appropriate strand of the cloned DNA. 
After subcloning an appropriate segment of the gene to 
be mutagenized into an Ml3 vector by standard methods, tem-
plate DNA is prepared from the single stranded packaged 
phage by extraction with phenol as described by Messing 
( 9) • 
Single stranded template DNA (0.5 pmoles) is combined 
with 20 pmoles of phosphorylated mutagenic oligomer, and 20 
pmoles of the Ml3 universal sequencing primer, in 120 mM 
HEPES buffer pH 7.5, 6 mM NaCl, 8 mM MgCl2, 10 mM DTT, in a 
12 microliter volume. This solution is heated to 90°C for 5 
minutes and allowed to cool slowly to room temperature. The 
synthesis of the second strand is 
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initiated by adding 3.5 microliters of a solution 
containing 7.5 nanornoles of each of the four 
deoxynucleotide triphosphates, and 4 units of the Klenow 
(large) fragment of E. coli DNA polymerase I 
(Boehringer-Mannheim). The reaction mixture is incubated at 
15°C for 4 hours. The phage T7 gene 32 protein has been 
recently used to improve polymerase read-through and is 
reported to increase the yield of covalently closed double 
stranded circles dramatically (Charles Craik, personal 
communication, 1984). 
After incubating at 1soc for 4 hours, 20 nanornoles of 
ATP and 400 units (as defined by the supplier, New England 
Biolabs) of T4 DNA ligase are added and the reaction is 
continued at 1soc for another 12 hours. 
The resulting DNA is purified by extraction with phenol 
and chloroform, and precipitated with ethanol. The DNA is 
dried and redissolved in 1/10 TE buffer and used to 
transform an appropriate host such as E. coli JM103 or 
JM109. 
The colonies carrying mutant phage are identified best 
by hybridizing the mutagenic oligonucleotide, now labeled 
with 32p, to nitrocellulose (Shleicher & Schue!!, BA85) 
filter replicas of the plated transformants. Prehybridiza-
tion is done at room temperature for 30 minutes in a solu-
tion containing 0.2% SDS, lOX Denhardt's (22), 0.1 mg/ml 
sonicated and denatured salmon sperm DNA, 1 mM sodium 
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orthophosphate, lmM sodium pyrophosphate, 0.5 mM ATP, and 
6X sse buffer. 
Then the nitrocellulose filters are hybridized for at 
least 2hours at room temperature in a solution containing 
0.2% SDS, lOX Denhardt's (22), 0.25 mg/ml yeast tRNA 
(Sigma, phenol extracted), 1 mM sodium orthophosphate, lmM 
sodium pyrophosphate, 0.5 mM ATP, 6X SSe buffer and 1 to 2 
ng/ml of the labeled oligonucleotide . 
The filters are washed in 6X sse, three times for five 
minutes, first at room temperature and then at 5 degrees 
below the estimated Td, and at higher temperatures, until a 
discriminating temperature is found; autoradiograms should 
be taken after each wash. 
Any positives found can be confirmed by dot blots. 
Several single plaques presumed to be positive are picked 
into 2 ml of broth each, and incubated for 4 to 6 hours 
with good aereation. The cells are centrifuged out and 2 
microliters of each supernatant are spotted on dry, un-
treated nitrocellulose and baked for 90 minutes in a vacuum 
oven at aooe. The same prehybridization and hybridization 
conditions described above should be used ; washing is also 
as above. 
After positives are confirmed, the mutant phages should 
be plaque purified and characterized by DNA sequencing. 
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RESULTS and DISCUSSION 
In Chapter I a double mutation was introduced using a 
sixteen base oligonucleotide that was complementary to the 
wild type template in the region of the active site of beta 
lactamase at 14 out of 16 bases. In that case two 
mismatches were present of necessity, but we argued that it 
would be advantageous in site specific mutagenesis of pro-
tein genes, to design mutagenic oligomers with double base 
mismatches even for single aminoacid mutations whenever the 
degeneracy of the genetic code allows it. Whereas single 
base substitutions had been previously obtained and 
identified by colony hybridization (10), and model studies 
(26) indicated that single base mismatches in short 
heteroduplexes could be detected by in situ hybridization, 
the relative merits of using a single versus a double base 
mismatch in screening for mutants had not been tested. 
The two oligonucleotides used to introduce the 
ser70-->thr70 (a hexadecamer) and ser70-->arg (a pentadeca-
mer) were designed to span the same sequence as the hexade-
camer used for the double mutation in Chapter I; these two 
however, introduce a single base change each. A homology 
search revealed no competing sites on either strand of the 
template, pBR322 (27), that match either oligonucleotide at 
more than 11/15 bases; this is quite acceptable since an-
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nealing of the mutagenic oligomers at the desired site will 
occur with 15/16 matches and 14/15 matches respectively. 
The oligonucleotides 5'ATGATGCGCACTTTT and 
5'AATGATGACCACTTTT have virtually no self complementarity. 
The hexadecamer was synthesized by the phosphotriester 
method (15) and purified by HPLC in K. Itakura's laboratory 
at the City of Hope and the pentadecamer was synthesized by 
the phosphoramidite (16) method by Steve Schultz. The 
latter was purified by preparative gel electrophoresis 
through 20% polyacrylamide 40% urea. An autoradiogram of 
the 5'-32p labeled oligonucleotide before and after 
purification is shown in Figure II-4; the purity of the 
HPLC purified oligonucleotides is comparable. No further 
characterization was done prior to mutagenesis. 
Since the beta lactamase gene is carried by the small 
double stranded plasmid pBR322 (27) and there are no 
compelling reasons to use a single stranded vector, the 
same strategy for mutagenesis in double stranded DNA used 
in Chapter I and described in greater detail at the begin-
ning of this chapter was used again. 
Appropriate concentrations of supercoiled plasmid, 
ethidium bromide and restriction endonuclease Hpaii were 
determined by trial reactions which were analyzed by gel 
electrophoresis on 1.2% agarose in 0.04 M Tris acetate 
buffer pH 8.0. Figure II-5 is a photograph of the stained 
gel. The conditions used in lane (d) were chosen for the 
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FIGURE II-4 
Autoradiogram of a synthetic 32p labeled 
oligodeoxynucleotide (a pentadecamer) before and after 
purification by preparative gel electrophoresis, analyzed 






Treatment of this nicked DNA with E. coli exonuclease 
III results in material that runs as a smear on an agarose 
gel, and on prolonged incubation the amount of DNA dimin-
ishes until it is no longer detectable. This can be ex-
plained as follows: Initially as shown in Figure II-3, a 
population of open circular forms of the plasmid with vary-
ing amounts of single stranded regions are generated, and 
their mobilities vary depending on the size of the single 
stranded regions, so a smear, rather than a band is seen. 
On prolonged incubation, molecules with multiple nicks are 
digested extensively, giving rise to a very heterogenious 
population which would be dispersed throughout the length 
of the gel. Also, the presence of nonspecific nucleases in 
commercial preparations cannot be excluded, and they may be 
responsible for the digestion of any remaining intact sin-
gle stranded circles. 
Since it is cheap and easy to prepare a large supply of 
nicked plasmid, a simple way to make sure one has enough 
good template for a successful mutagenesis experiment is to 
use a large amount of nicked plasmid in each experiment. I 
have found that increasing the amount used to 5 micrograms 
is more than adequate. This approach has the further advan-
tage of allowing for electrophoretic analysis after each 
step. The efficiency of the chemical synthesis methods 
currently in use contribute to make this feasible since the 
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FIGURE II-5 
Gel electrophoretic analysis of pilot reactions used to 
determine the best conditions for nicking plasmid DNA. Lane 
(a) is a control containing 0.37 ug of supercoiled pBR322. 
Each reaction contained 0.37 ug of plasmid DNA, 20mM 
Tris-HCl pH 7.4, 7mM MgCl2, lmM DTT, and increasing amounts 
of ethidium bromide (0.1, 0.2, 0.4, 0.6, and 0.8 ug) in 
lanes (b) through (f). The reactions were started by adding 
0.45 units of restriction endonuclease Hpa II and incubated 
at room temperature for one hour; the final reaction volume 
was 10 ul. They were stopped by adding 1/10 volume of 0.1 M 
EDTA and chilling on ice. 
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a b c d e f 
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amount of oligonucleotide required per experiment is only a 
fraction of the amount routinely synthesized. 
Therefore, for each of these two mutations, 5 ug of 
nicked pBR322 were digested with 30 untis of E. coli exonu-
clease III (BRL) for 15 minutes at room temperature. . The 
reactions were stopped and a 50 fold molar excess of each 
primer was annealed (in separate reactions) as described in 
the methods section of this chapter. In both cases the 
repair reactions were done first at room temperature, and 
then at lSOC for 4 hours or overnight. 
In the case of the ser70-->thr mutation approximately 
4500 independent transformants were screened after the 
second transformation. Twenty-five colonies appeared to 
hybridize strongly after washing at 37oc. Plasmid was 
prepared from seven of these colonies and two of the 
plasmids retained the bound probe after washing in 6X sse 
at 45oc. 
One of these clones was streaked, colony purified and 
the mutation was confirmed by DNA sequencing (Maxam & 
Gilbert method). 
In the case of the ser70-->arg mutation, at least 3000 
to 4000 colonies were screened. Twenty-one appeared to be 
possible mutants, and one of them was confirmed by hybrid-
ization to the plasmid on a dry gel. 
In this case, screening was done after the first 
transformation, so the colony identified carried a mixed 
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population of wild type and mutant plasmids; still, it was 
identified against a background of colonies carrying a 
plasmid that differs by a single base. 
Plasmid DNA was prepared (22) from this clone and com-
petent E. coli were transformed; 96 single colonies were 
tested for ampicillin and tetracycline resistance. 34/96 
colonies grew on both ampicillin and tetracycline. 62 of 
the 96 did not grow on ampicillin. The same 62 bound the 
probe much better than the wild type control. A few of the 
ampicillin resistant colonies also bound the probe better 
than the control. When plasmid was made from these colonies 
it was apparent that it was a dimeric form which probably 
carried the mutant sequence in one site and the wild type 
sequence in the other. 
This does not represent a problem, since if necessary 
the dimers could be cut, diluted and religated in order to 
transform again to obtain a pure strain. 
Our collaborator Patricia L. Foster is in the process 
of characterizing the ser70-->arg mutation and developing 
the assay for induced G-C to T-A transversions. Her prelim-
inary results indicate that indeed both aflatoxin Bl, which 
has been shown to produce transversions (2) and the 
alkylating agent methyl methane sulfonate (MMS) induce a 
high rate of reversion to ampicillin resistance, whereas 
other mutagens such as nitrosoguanidine do not. 
In producing these two mutations, it became immediately 
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obvious that a single mismatched base is sufficient to pro-
duce reliable hybridization data to distinguish wild type 
from mutant colonies even when mixed genotype colonies are 
screened; this agrees with a growing number of reports in 
the literature (eg., 10, 24, 28). The frequency with which 
mutants were found by this method ranged from 0.1% to about 
0.5% of all the colonies screened. 
The mutation cys77-->ser was obtained by mutagenesis on 
Ml3; the Eco Rl - Pstl fragment of pBR322 containing the 
amino terminal part of the Ampr gene, was subcloned into 
the phage vector Ml3mp8, and E. coli JM103 was used as a 
host (9). The sequence of the mutagenic oligonucleotide was 
5'-CCACTTAGCAGAACT-3', and no competing sites that matched 
at more than 10 out of 15 bases were found. Figure II-6 
shows a nitrocellulose filter replica where some positives 
are apparent. Figure II-7 shows a dot blot hybridization 
after a room temperature wash (A), and after washing at a 
discriminating temperature (B). This mutation was confirmed 
by DNA sequencing by the chain terminating method, using an 
oligonucleotide synthesized to sequence through this region 
and the active site region. 
In this case the mutations were obtained at a -frequency 
of 1% to 2% over background, with the added advantage of 
immediately confirming the mutation by sequencing on the 
Ml3 template. 
The Eco Rl - Pstl fragment now carrying the mutation 
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FIGURE II-6 
Autoradiogram of a nitrocellulose filter replica of phage 
infected colonies washed (A) at room temperature, and (B), 
at 380C in 6X SSC, after hybridization to the mutagenic 
oligodeoxynucleotide 5'-CCACTTAGCAGAACT. The hybridization 
conditions are described in the Methods section. The arrow 










Autoradiogram of a dot blot. 
Several phage infected colonies that appeared to be mutants 
in a previous screening (Figure II-6) were cultured in 
broth and after centrifugation the phage containing 
supernatants were spotted on a nitrocellulose membrane as 
described in Methods. After a two hour hybridization to the 
mutagenic oligonucleotide, S'CCACTTAGCAGAACT, at room 
temperature in the conditions described in the Methods 
section of this chapter, the membrane was washed at room 
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was subcloned into pBR322 and the cells harboring this 
plasmid were shown to be ampicillin resistant at 250 ug/ml 
at both 37oc and 42°C. Plasmid DNA was prepared from these 
ampicillin resistant colonies and hybridization to the 
mutagenic oligonucleotide confirmed that the plasmid indeed 
carries the mutant sequence. 
J. J. Neitzel has prepared beta-lactamase from this 
mutant strain and has made some preliminary observations 
regarding its thermal stability. These results will be 
discussed in Chapter IV along with the properties of other 
mutant proteins. 
Table II shows the oligonucleotides used to produce the 
mutations in this chapter and in Chapter I, their estimated 
melting temperatures, and the temperature that was found, 
experimentally, to discriminate between wild type and mu-
tant sequences. There is reasonable agreement with the 
predicted Td, and there is also (as expected) a correlation 
between the difference in melting temperatures of DNA 
duplexes as a function of the number of mismatched bases 
































The sequences of several oligonucleotides used to introduce 
mutations in the beta-lactamase gene are shown; mismatched 
bases are indicated in bold face characters, and the 
corresponding wild type bases are shown below in parenthesis. 
Td is the melting temperature estimated from the empirical 
relationship Td= 4 X (G-C base pairs) + 2 X (A-T base pairs) 
(29). The discriminating temperature is the lowest wash 
temperature (in 6X SSC) at which a difference in 
hybridization was observed between a perfectly matched DNA 
duplex (oligomer/mutant) and the corresponding heteroduplex 
(oligomer/wild type) . 
*From Jim Neitzel's data. 
**From Steve Schultz's data. 
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STRUCTURAL VARIANTS BY ANOTHER APPROACH 
IMPOSING A FUNCTION 
RATHER THAN IMPOSING A STRUCTURE 
In previous chapters, site directed mutagenesis was 
used as a means of deliberately imposing a known predeter-
mined structural change on a protein in order to study its 
effect on function. In this chapter a different but comple-
mentary approach will be explored as a probe of structural 
requirements for activity: a function will be imposed in 
order to find out which structures will satisfy this 
requirement. 
Imposing a function or in other words selecting a 
phenotype, has been an extensively used tool in classical 
genetics and now, in combination with the techniques of 
site specific mutagenesis and other recombinant DNA 
methods, it has become an even more powerful tool. In the 
study of protein structure and function, site specific 
mutagenesis allows one to precisely define a site or region 
to be studied by imposing a known structure (1): 
subsequently, many alternative structures can be obtained 
at the selected site and screened for their ability to 
function. For example, if a protein of interest confers a 
selectable phenotype, a mutation can be introduced at a 
specific site to produce a negative phenotype. Then, any 
one of a variety of random mutagenic strategies can be 
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applied under selective pressure (imposing a function) in 
order to recover revertants to a positive phenotype 
(functional protein). The analysis of any revertants 
obtained should give information on the nature of the 
structures allowed by the constraints of the specified 
function. The value of the information obtained will depend 
in part on how complete a search for alternative structures 
can be designed. 
One can expect reversions at the primary site which 
restore function either by using the same residue found in 
the wild type protein or by replacing it with a different 
residue capable of performing the same role. In some cases 
one can also expect revertants that restore activity by a 
compensating change in structure at a secondary site (2), 
while retaining the mutation introduced initially at the 
primary site; I shall refer to these as second site 
revertants. These are probably more likely to occur if the 
primary mutation affects the folding of the protein; if the 
primary mutation affects a residue with a very specific 
role such as a catalytic residue in an enzyme, then it is 
far more probable to expect revertants only at the primary 
site. Whether substitutions at a catalytic site are possi-
ble or not, can yield significant insights into the mechan-
ism involved. 
A recent example of the use of reversion experiments as 
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a guide to major structural features is provided by the 
study of the secretion of the maltose binding protein. A 
deletion mutant which remained cell bound reverted to a 
secreted protein only when a certain number of hydrophobic 
residues were reinserted, restoring at least in part the 
length of the hydrophobic stretch lost due to the deletion 
(3). The classical studies on the lac repressor protein (4) 
are another example of this type of approach, but done with 
the limitation of only studying sites at which chain 
terminating mutations could be obtained by random 
mutagenesis. 
Beta-lactamase also provides an interesting system in 
which to apply these experimental approaches. It confers a 
selectable phenotype, and as pointed out in previous 
chapters, it meets all the requirements for in vitro mu-
tagenesis: its gene is cloned, has been entirely sequenced 
and the enzyme is expressed abundantly. It is secreted into 
the E. coli periplasmic space and when the expression is 
controlled by a highly efficient promoter such as the tac 
(5) or trp (6) promoters, up to 4 mg of pure protein per 
liter of culture can be obtained. 
In previous experiments a double mutant of beta lac-
tamase (ser70-->thr~ thr71-->ser) was obtained by oligonu-
cleotide directed mutagenesis (Chapter I) and was shown to 
have no detectable enzymatic activity~ the gene for this 
mutant beta-lactamase with the sequence -thr70-ser71- at 
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the active site differs from the wild type gene by two base 
pairs (Table I, Chapter II). No single base pair 
substitution in the mutant gene can give rise to a gene 
encoding the wild type protein sequence (-ser70-thr71-); 
therefore, this double mutant can be used in reversion 
experiments in which base changes can ocurr only at single 
sites with an appreciable frequency, to ask which sequences 
other than the wild type (if any) can restore activity, 
without a high background of wild type revertants to 
obscure them. 
With this particular arrangement in which the two con-
served aminoacids at the beta-lactamase active site have 
been mutated, one can ask whether activity can be recovered 
by any single aminoacid substitution at either one of the 
two altered positions while maintaining the other mutant 
residue unchanged. 
For a replicating bacterial cell one can expect a rate 
of spontaneous mutagenesis of the order of 1/106 per locus 
or structural gene per generation (7) for forward 
mutations, and a somewhat lower rate for direct reversions, 
which require a mutation at a particular base pair within 
that gene. Consequently, the probability of n mutagenic 
events occurring at the same locus or gene would be no 
greater than (l/106)n; therefore, when plating -1 x 109 
' 
rapidly replicating cells, one should expect to see only 
single base pair mutations if no mutagen is used. 
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However, since a single base change from a given codon will 
only generate a particular subset of aminoacids, some 
aminoacid replacements will be excluded in this 
experimental strategy, and other approaches are necessary 
to explore all possibilities. This will be discussed 
further in the Results and Discussion section of this 
chapter. 
Another way in which random and site specific mu-
tagenesis can be combined advantageously is to direct mu-
tagenesis away from a specified region in order to search 
for second site revertants, also known as intragenic 
suppressors. Again the inactive beta lactamase double mu-
tant can be used (Figure III-1): annealing and enzymatical-
ly extending the oligonucleotide initially used to intro-
duce the double mutation to an appropriate template allows 
one to protect the primary site while subjecting the entire 
template to mutagenic strategies directed at single strand-
ed DNA. Again, protecting the primary mutation site from 
mutagenesis prevents a large background of active colonies 
due to reversion to the wild type sequence, in this case by 
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MATERIALS AND METHODS 
Bacterial strains 
Mutagenesis and/or reversion experiments were done in 
E. coli strain LSI (1), and E. coli JM103 was used as a 
host for phage Ml3mp8 (8) used in DNA sequencing. Culture 
media was L broth or L agar unless otherwise indicated. 
D~ 
Plasmid DNA was prepared by the alkaline lysis method 
(9). The plasmids used were pBR322 (10) and its derivative 
carrying a double mutation (Chapter I) 22G9. Sequence 
determination was done by the Sanger method (11) on a 700 
baase pair EcoRI-Psti fragment subcloned into Ml3mp8; a 
synthetic oligonucleotide complementary to the insert at a 
site 50 bases away from the sequence of interest, was used 
as a primer. 
Enzymes: 
Restriction enzymes and exonuclease III were obtained 
from BRL, T4 DNA ligase from New England Biolabs, and DNA 
polymerase (Klenow fragment) was from Boehringer-Mannheirn. 
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RESULTS AND DISCUSSION 
REVERTANTS 
In order to ask questions regarding the possible ami-
noacid sequences at the active site of beta lactamase that 
might be compatible with at least some degree of catalytic 
activity, a simple phenotypic screen was carried out as 
follows. 
E. coli strain LSl harboring the doubly mutant plasmid 
22G9, that encodes an inactive beta lactamase (ser70-->thr; 
thr71-->ser , Chapter I), was cultured in broth to a cell 
density of 5xlo8 cells/ml, and then plated on L agar con-
taining lOmg/1 of ampicillin. The plates were incubated 
overnight at 37oc, and seven colonies were found that had 
reverted to ampicillin resistance. Plasmid DNA was obtained 
from each of these revertants (Rl, R2, R3, R4, RS, R6, R7), 
and used to transform competent E. coli which were plated 
on L agar plates containing 20mg/l of tetracycline. 
Transformants were obtained from six of the plasmids (all 
except R7); Rl, R2, R3, R4, and R6 also grew on lOmg/1 of 
ampicillin as well as on tetracycline, but RS did not. 
Therefore five of the revertants had plasmid encoded 
ampicillin resistance. Each of the corresponding transfor-
mants was colony purified, and plasmid DNA was prepared. 
Plasmids were digested with EcoRI and analyzed by gel elec-
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trophoresis on 1.2% agarose ; since plasmid Rl appeared to 
be different in size and restriction sites, it was assumed 
to be a contaminant and was not characterized further. 
Plasmids R2, R3, R4, and R6 were characterized by hybridi-
zation experiments, and R2 by DNA sequencing as well. 
Figure III-2 shows the result of a hybridization exper-
iment in which the plasmids from the four revertants and 
two control plasmids were hybridized to the oligomer 5'-
32p- AATGATGAGCTCTTTT; the two controls were pBR322 
(-ser70-thr71-) and the double mutant 22G9 (-thr70-ser71-). 
At room temperature the hybridization probe, which codes 
for the sequence -ser70-ser71-, binds to all six plasmids 
and no significant difference in signal can be observed. 
However, after washing at a higher temperature it only 
remains bound to the plasmids from the four revertants. In 
Figure III-3 this result (panel B) is compared to another 
experiment in which the same set of plasmids were hybri-
dized to the oligomer used to obtain the double mutant 22G9 
(panel A). Clearly, the probe that matches the DNA sequence 
of the inactive double mutant used in the reversion experi-
ment binds only to the DNA of the inactive parent , but not 
to the DNA of any of the ampicillin resistant revertants. 
Table I summarizes the data, showing the DNA and amino 
acid sequences of the controls in the region of the beta 
lactamase active site as well as the DNA sequence of the 
two hybridization probes. 
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FIGURE III-2 
Hybridization of an oligonucleotide coding for the sequence 
ser70-ser71 to DNA from four revertants to ampicillin 
resistance: autoradiograms of a dry gel after hybridization 
of the oligonucleotide 5'-AATGATGAGCTCTTTT to linearized 
plasmid DNA from the four revertants, R2, R3, R4, R6, and 
two controls, pBR322 and the double mutant 22G9. The dry 
gel hybridization technique is described in Chapter I, 
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Hybridization of two different oligonucleotides to plasmid 
DNA from two controls, pBR322 and 22G9, and from four 
revertants to ampicillin resistance. The technique and 
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PROBE: 5AATGATGACCTCTTTT 5' AATGATGAGCTCTT TT 
Lane a. pBR322 (· · · AGCACT · · ·) 
Lane b. 22G9 ( · · · ACCTCT · · · ) 
Lanes c-f. Revertants to AmpR 
PLASMID SEQUENCE 
pBR322 AGC ACT 
-ser-thr-





















* Both probes are hexadecamers and their complete sequences 
are s•-32P-AATGATGACCTCTTTT-3'and 
s•-32p-AATGATGAGCTCTTTT-3' 
The + and - singns indicate whether each of the probes hy-
bridized to the immobilized plasmid DNA's after washing at 
a discriminating temperature. 
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These experiments demonstrate once again (12, 13) that 
two sequences differing by one or more bases can be distin-
guished from each other by hybridization to oligomeric 
probes. 
All four revertants to ampicillin resistance exhibit 
similar properties while being clearly different from ei-
ther of the two controls, so one can infer that their DNA 
sequences are identical. It is not clear whether these four 
clones represent four separate reversion events or whether 
they are siblings derived from a single revertant. DNA 
sequencing of revertant R2 by the Sanger method (11) con-
firmed the sequence AGCTCT which codes for ser70-ser71, in 
agreement with the hybridization results. 
Note that only certain aminoacid substitutions were 
possible in this experiment; Table II shows the codons that 
can arise by a single base change at either position 70 or 
71 of the beta-lactamase double mutant 22G9 (thr70-ser71). 
taBLE II 
ACC(thr70)-->ACA(thr) ACG(thr) ACT(thr) 
AAC(asn) AGC(ser) ATC(ile) 
GCC(ala) CCC(pro) TCC(ser) 
TCT(ser71)-->TCA(ser) TCG(ser) TCC(ser) 
• 
TAT(tyr) TGT(cys) TTT(phe) 
ACT(thr) GCT(ala) CCT(pro) 
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TWo different serine codons could arise by a single 
base change in the threonine codon ACC, yet only one (AGC) 
was obtained. This could mean either that the four rever-
tants are siblings or that CG to GC transversions, involv-
ing a transient CC mismatch, occur with greater frequency 
than AT to TA transversions with a transient AA mismatch. 
It is interesting to note in this regard that CC (and AG) 
mismatches are not corrected by the Streptococcus pneu-
moniae Hex mismatch repair system, whereas AA mismatches 
(and others) are corrected (14). It is not known whether 
mismatch repair in E. coli is carried out by a system with 
similar properties. 
A number of substitutions, including thr70-->cys which 
would require a double base change, would not have been 
examined in the search for revertants described above. 
Other strategies are necessary to ascertain that all 
possible replacements have been produced at a given site, 
while demanding a function under selective conditions, and 
in order to make negative information more significant. One 
such approach is currently being evaluated by Steve Schultz 
using beta lactamase as a model system: it consists of 
cloning a mixture of synthetic oligomers which code for all 
possible replacements at one site while maintaining the 
wild type sequence at all other sites. Since in the case of 
most proteins it is possible to engineer restriction sites 
without altering the aminoacid sequence, it usually should 
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be possible to limit the length of the mixture of 
synthetic oligomers to a reasonable number of bases. Other 
approaches inlude using several different types of chemical 
mutagens to increase the frequency of different kinds of 
base changes, or the misincorporation of base analogues 
such as the excision resistant alpha-thionucleotides (15). 
However, even when all types of base changes are achieved 
by random mutagenesis , one must still be aware of the 
vastly different frequencies that separate single base 
changes from double and multiple base changes . 
The only catalytically active structures yet found for 
beta lactarnase all posess a primary nucleophile at position 
70, either the hydroxyl group of serine in the wild type 
and in these revertants, or the sulfhydryl group of cys-
teine in thiolactamase (ser70-->cys) (6, 16). The conserved 
threonine at position 71, however, can be replaced by ser-
ine and possibly by other residues without destroying cata-
lytic activity, although it is known that in S. aureus 
beta- lactarnase replacement of threonine by the bulky, hy-
drophobic side chain of isoleucine at position 71 virtually 
abolishes activity (17). Some of the properties of the R2 
beta lactamase (-ser70-ser71-) will be discussed in Chapter 
IV. 
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SECOND SITE REVERTANTS 
As an example of an approach to determine whether 
changes outside the region of the active site could restore 
catalytic activity to a protein that had a threonine at 
position 70, the synthetic oligonucleotide 5'-AATGATGAC 
CACTTTT was hybridized to a plasmid DNA template prepared 
from the inactive beta lactamase double mutant 22G9 
(-thr70-ser71-; ACC TCT) and extended in the conditions 
described below and as shown schematically in Figure III-J .. 
The binding of the synthetic oligonucleotide will protect 
the region of the active site from mutation during the in 
vitro replication of the template carried out in the pres-
ence of limiting amounts of each of the four deoxynucleo-
tide triphosphates in turn. In these conditions one can 
expect an increased incidence of nucleotide misincorpora-
tion at sites complementary to the limiting nucleotide. 
The template was prepared from plasmid DNA by the 
method described in detail in Chapter II, Methods section 
(b). Briefly, it consists of introducing single stranded 
nicks using an endonuclease (Hpaii in this case) in the 
presence of ethidium bromide and treating the nicked 
material with E. coli exonuclease III. In Chapter II, I 
argued that a limited exonuclease digestion would be 
preferable when preparing a template for mutagenesis . In 
this case, however, exonuclease digestion was deliberately 
extensive in order to obtain completely single stranded 
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circles so that the only primer available for DNA polym-
erase would be the synthetic oligonucleotide. Nicked DNA 
(20 ug) was digested for 60 minutes at 37oc with 40 units 
of E. coli exonuclease III in the appropriate buffer 
conditions(see Chapter II); the enzyme was heat inactivated 
in the presence of chloroform and the solution was 
lyophilyzed. 
160 pmoles of the synthetic oligonucleotide represent-
ing a 40 fold molar excess was annealed to the template in 
a 12.5 ul volume of 0.5 M NaCl (and the salts carried over 
from the previous reaction) by heating in a boiling water 
bath for 5 minutes and allowing it to cool slowly to room 
temperature. The annealed material was divided into five 
aliquots and five reaction mixtures were prepared contain-
ing 0. 5mM ATP and the concentrations of deoxynucleotide 
triphosphates indicated below. 
Reaction dATP dGTP dCTP dTTP 
A 0.5uM 0.5mM 0.5mM 0.5mM 
G 0.5mM 0.5uM 0.5mM 0.5mM 
c 0.5mM 0.5mM 0.5uM 0.5mM 
T 0.5mM 0.5mM 0.5mM 0.5uM 
Control 0.5mM 0.5mM 0.5mM 0.5mM 
The buffer and salt concentrations were adjusted to 100 
mM NaCl, 10 mM MgCl2, 20 mM Tris-HCl pH 7.5, 10 mM DTT 
(dithiothreitol) and the final reaction volume was SOul. 
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The reactions were started by adding 4 units of the Klenow 
fragment of DNA polymerase I from E. coli, and 100 units of 
T4 DNA ligase. They were incubated 15 minutes at room 
temperature and overnight at 15oc. Then 1 ul of a lOrnM 
solution of the limiting deoxynucleotide triphosphate was 
added to each reaction, as well as another aliquot (as 
above) of each of the two enzymes. Incubation was continued 
for one hour at room temperature, and the reaction products 
were purified by extraction with phenol and chloroform and 
precipitated with ethanol. The pellets were dried , 
redissolved in 40ul of TE buffer and an aliquot was used to 
transform competent E. coli LSl. The cells were plated on L 
agar plates containing either 10 ug/ml of Ampicillin or 20 
ug/ml of tetracycline and incubated overnight at 370C. 
The total possible number of transformants examined 
(from all four reactions) was 15,000, as determined from 
the control transformation plated on tetracycline. This 
refers to the transformation done with the control DNA 
which was repaired in non-mutagenizing conditions. No ac-
tive second site revertants were isolated by this 
procedure. 
In order to draw a significant conclusion from a nega-
tive result such as this, it would be necessary to screen a 
much larger number of molecules subjected to mutagenizing 
conditions. Even then, some caution would be appropriate 
because one can never be absolutely certain that every pro-
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tein structure with threonine at position 70 was examined 
in the search for second-site revertants. This negative 
result, however, is consistent with other data that sug-
gests that a primary nucleophile at position 70 is an 
essential requirement for lactamase activity. 
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SOME MUTANTS OF BETA-LACTAMASE 
AND THEIR PROPERTIES 
The beta-lactamase from E. coli is a small, monomeric, 
globular protein of molecular weight 28,500 (1), with ap-
proximately 40% alpha helical content (2). Its crystal 
structure has not yet been solved at high resolution, but a 
four angstrom resolution electron density map has been re-
ported (2). 
There are several different beta lactamases from vari-
ous bacterial sources, which Ambler (1) has classified as 
classes A and B; a third class C, including the chromo-
somally encoded beta lactamases of E. coli Kl2 (ampC) and 
Pseudomonas aeruginosa shares sequence homology distinct 
from that characterizing class A enzymes (3). Class A beta 
lactamaseses appear to have a common evolutionary origin 
and to be related to transpeptidases (4); Class A enzymes 
include the beta lactamases from B. cereus, B. licheni-
formis, s. aureus and E. coli (the subject of this study), 
all of whose aminoacid sequences are known and which exhi-
bit considerable sequence homology and share a number of 
mechanistic features. Class B enzymes of molecular mass 
23,000 are unrelated, showing little or no aminoacid se-
quence homology and a different catalytic mechanism which 
requires a metal cofactor, usually Znii (1); Class C en 
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zymes are unrelated as well, having a different molecular 
weight and aminoacid sequence. In addition, there are many 
beta lactamases that have not been classified due to insuf-
ficient aminoacid sequence data and mechanistic 
information. 
The class A beta lactamases are serine hydrolases which 
catalyze the ring opening of bicyclic beta lactams such as 
penicillins and cephalosporins, but are not capable of hy-
drolyzing linear peptides (5); it has been recently shown, 
however that these enzymes are capable of hydrolyzing cer-
tain monocyclic beta lactams (6), and even acyclic depsi-
peptides (RCONH-CR1R2COO-CHR3COOH) (7) albeit at a very 
slow rate. The apparent order of substrate preference 
(bicyclic beta lactam > monocyclic beta lactam > 
depsipeptides >> linear peptides) appears to reflect the 
susceptibility of each type of compound to nucleophilic 
cleaveage. This is consistent with the proposed mechanism · 
of catalysis which entails a nucleophilic attack of the 
active site serine hydroxyl group on the carbonyl carbon of 
the substrate. Serine 70, (in Ambler's numbering system), 
(1) has been covalently modified by the irreversible 
inhibitor 6-beta bromopenicillanic acid in the B. cereus 
beta lactamase I (8, 9), and similar inhibitors (10) modify 
the corresponding serine in the homologous plasmid encoded 
E. coli enzyme. A covalent acyl-enzyme intermediate was 
demonstrated spectroscopically using the very poor 
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substrate cefoxitin and was shown to have the 
characteristics of an aliphatic ester consistent, 
therefore, with an acylserine (11). 
The aminoacid sequence information on class A beta lac-
tamases (1) indicates that the enzymes are made of a single 
polypeptide chain varying in length from 264 to 273 aminoa-
cids for the mature soluble proteins. There is a conserved 
serine-threonine dyad at the active site, but the role of 
the threonine residue in catalysis is not understood, 
although there is a report of virtually complete loss of 
activity in a mutant S. aureus beta lactamase with isoleu-
cine (instead of threonine) adjacent to serine. No other 
aminoacid residues have been directly implicated in the 
catalytic mechanism, and although the existence of a second 
internal nucleophile or general base is plausible, by 
analogy with serine proteases, none has been demonstrated; 
reference was made by Ambler to another almost inactive 
mutant of S. aureus beta lactamase in which conserved 
aspartate 179 was substituted by asparagine, but since the 
characterization has not gone beyond identifying the 
aminoacid lesion in a randomly obtained mutant, no 
conclusions can be drawn about the role of the residue. 
Evidence indicates these enzymes are biosynthesized as 
precursors, and in the case of the E. coli enzyme encoded 
by the plasmid pBR322 the processing of the precursor to 
the mature enzyme and its secretion into the periplasmic 
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space have been studied (12, 13, 14). 
Koshland and Botstein (12, 13) demonstrated that beta 
lac tamase is translocated posttranslationally across the 
inner membrane and that 23 N terminal aminoacids are 
removed during or immediately after translocation to yield 
the mature periplasmic enzyme. Mutations in the signal 
sequence and in other regions of the protein were used to 
characterize different steps in the process (15). Whereas 
the carboxyl terminus is not required for for 
translocation, it seems to be necessary for the enzyme to 
be completely released as a soluble molecule in the 
periplasm. Apparently the energy required for export of 
beta lactamase is fulfilled by the total protonmotive 
force, with no specificity for either the membrane 
potential or the pH gradient alone (16). 
Other mutants of beta lactamase have been obtained by 
Shortie and Botstein (unpublised results) by segment 
directed mutagenesis, and screening for those that had re-
duced resistance to ampicillin. Interestingly, in the N 
terminal segment of the mature enzyme including the first 
48 aminoacids the mutations found with reduced catalytic 
activity had alterations in one or another of the three 
conserved residues found in this region of the protein. 
These mutants have not been characterized further, and so 
one can only speculate on the reasons why each one affects 
the function of the enzyme; the possibilities include al-
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teration of the final folded form of the protein, changes 
in the kinetics of the folding pathway, and even direct 
involvement of these residues in secretion, in substrate 
binding or in catalysis. 
In order to study the catalytic properties of the en-
zyme, several specific aminoacid substitutions were 
designed and introduced in the active site region. As men-
tioned above the role of the active site serine had been 
fairly well established by chemical modification and kinet-
ic studies by 1980, but the possible role of the adjacent 
conserved threonine was not; in addition, it seemed possi-
ble that perhaps threonine could function in place of ser-
ine in catalysis. In order to gain further understanding of 
the role of these residues and the possible use of a sec-
ondary nucleophile in catalysis, we set out to obtain 
mutants of beta lactamase containing all of the permuta-
tions of serine and threonine at positions 70 and 71. 
The first one obtained by oligonucleotide-directed mu-
tagenesis was the double mutant described in Chapter I • 
The mutant sequence -ser70-ser71- was obtained as a rever-
tant of this inactive mutant that had regained enzymatic 
activity (Chapter III). The mutant sequence, -thr70-thr71-
was obtained by oligonucleotide-directed mutagenesis as 
described in Chapter II. 
These aminoacid substitutions were not expected to af-
fect the overall conformation of the protein to any large 
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extent, so . it was somewhat surprising to discover early 
that the active mutant -ser70-ser71- appeared to be less 
resistant to proteolytic digestion than the wild type pro-
tein, and that its isolation required growing the bacteria 
at or below 300c. This observation suggested that the 
stabilit~ of the native conformation of the protein was 
altered with respect to that of the wild type, or that the 
folding kinetics had been altered enough to allow proteo-
lysis to occur before the mature protein could adopt the 
native conformation . 
Since more of the enzyme's properties than just ca-
talysis might have been altered, study of the effects of 
these mutations not only on the activity of the mature pro-
tein, but also on the processing and secretion of the pre-
cursor seemed essential. For example, the occurrence of 
internal sequences in the processed protein that neverthe-
less influence secretion has ample precedent (17, 12). To 
this end the mutants were transferred by in YiYQ recombina-
tion methods to a variant of the temperate Salmonella phage 
P22 that carries a copy of the beta lactamase gene, and 
which had been used previously (12) to study the secretion 
of beta lactamase. The genetic transfer of the three active 
site mutants was done in David Botstein's laboratory as 
described below in the Results and Discussion section • . 
One additional mutant of beta lactamase will be dis-
cussed in this chapter. The E. coli beta lactamase has been 
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shown to have a disulfide bond (18) between cysteines 77 
and 123, the only two cysteines present in the polypeptide 
chain. Evidence indicates that, whereas in the precursor in 
YiYQ the half cystines are reduced, as one might expect 
(12, 18), the enzyme precursor does form a disulfide bond 
if synthesized by in vitro translation. In vivo the 
formation of the disulfide bond occurs simultaneously with 
the processing of the precursor, and the role, if any, of 
the disulfide in the translocation and processing of the 
enzyme can only be tested with certainty by substituting 
one of the two cysteines with a different residue. 
In addition a beta lactamase with a single cysteine 
residue would be useful in preparing heavy atom derivatives 
for crystallographic studies, and in studies of the role of 
the disulfide bond in stabilizing the three dimensional 
structure of the protein. The study of disulfide bonds 
which are buried, as in this ~nd many other known cases 
(19), can be hindered by the fact that one needs to dena-
ture the protein in order to expose the bond to reducing 
agents. In many cases disulfide bonds occur because the 
position of the half cystines in the polypeptide chain is 
such that they come in close proximity to each other in at 
least one conformation of minimal energy. This conformation 
may or may not represent the overall energy miniumum of the 
processed, mature protein, and so studies of the thermal 
stability of a beta lactamase lacking a disulfide bridge, 
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can indicate whether its native conformation does indeed 
represent a global energy minimum even when the disulfide 
bond has been removed. When studies are undertaken by dena-
turing and reducing a protein, it is not always possible to 
regain an active protein by renaturation. Indeed, one can 
sometimes show that the irreversibility of a denaturation 
step is due to the fact that the protein becomes trapped in 
an ordered but inactive conformation, distinct from the 
native conformation, as in the case of human alpha inter-
feron in certain conditions (20). However, the inability to 
refold into the native conformation might also be due to 
destabilizing van der Waals contacts between two bulky -SH 
groups, whether derivatized or not . Therefore, studies on 
the role of disulfide cross links can be carried out more 
reliably in proteins in which the disulfide bond is removed 
genetically rather than chemically, as this avoids the 
uncertainty of interpreting the influence of bulky 
substituents. 
TO these ends, I introduced in E. coli beta lactamase 
the substitution cys77-->ser by oligonucleotide directed 
mutagenesis as described in detail in Chapter II. I chose 
serine because it occurs at the corresponding site in 
another class A beta lactamase (S. aureus) and the hydroxyl 
group is probably small enough to be accomodated opposite a 
reduced sulfhydryl group without disrupting the structure, 
while still maintaining a potential hydrogen bond acceptor 
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at position 77; alanine might have been another good choice 
because of its smaller size and the fact that it also oc-
curs at position 77 in B. cereus beta lactamase, another 
class A enzyme. 
In this Chapter, the results of pulse chase experiments 
designed to determine the rate of processing of the beta 
lactamase wild type and mutant precursors will be present-
ed, as well as some of the properties of the three active 
site mutant proteins, and of the cys77-->ser mutant. Secre 
tion studies of the latter have not yet been undertaken . 
Materials and Methods 
Phage and bacterial strains. 
The P22 phage and Salmonella typhimurium strains used 
in the work described in this Chapter were from David Bot-
stein's strain collection. The relevant characteristics of 
the bacterial strains are listed below. 
Strain DB4673 was used because it is more readily 
transformed than other Salmonella strains. DB6142 is a PolA 
mutant which does not allow plasmid replication. DB4381, · 
hisG46 del (bio-uvrB), is particularly sensitive to damage 
by ultraviolet light, and was used as the host in labeling 
and pulse chase experiments. DB7000, leuA-am414 is wild 
type s. typhimurium. DB7609 is a gal-, amp+ (low) 
derivative of DB7000 used in combination with the parent 
strain to identify phages which are either sensitive or 
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resistant to ampicillin. 
The P22 phage strains used were P22Ap3lpfrl, also 
called P22bla which carries a copy of the ampicillin resis-
tance gene identical to the one encoded by pBR322 in lieu 
of sequences in the secondary immunity region Irnrni. The 
phage P22bla 1752 carries the wild type ampicillin resis-
tance gene, and P22bla 4393 is a derivative that carries an 
ampicillin resistance gene with a large deletion (13). 
Red plate test for ampicillin resistance on P22bla strains: 
This method has been described in detail (21), so this 
is a brief description of the principle. This method was 
developed to rapidly assay a large number of phage for 
their ampicillin phenotype. Phage are plated on an agar 
plate which contains galactose, tetrazolium dye and 1 ug/ml 
of ampicillin, using a mixture of two tester strains: 
DB7000, a gal+, amp- strain, and DB7609, a gal-, amp+ 
strain. Its ampicillin resistance is very low, and is not 
due to secreted beta lactamase, therefore this strain does 
not save neighboring amp- cells. The galactose and 
tetrazolium act together as a color indicator which stains 
galactose fermenting cells red, leaving gal- cells 
colorless. Both tester strains are sensitive to P22 
infection and so phage plate whether or not they carry beta 
lactamase. The gal- strain, which is amp+ will give rise to 
colorless plaques when infected; the amp- cells 
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however will only survive when infected by ampicillin 
resistant phage, and since they ferment galactose, they 
will give rise to red plaques on the indicator plates. Thus 
ampicillin resistant phage plate as red plaques and 
sensitive phage as colorless plaques. 
Labeling of phage-encoded proteins: 
Labeling of phage-encoded proteins after infection, and 
pulse chase experiments were done as described by Koshland 
and Botstein (13). A 30 second pulse of 35s-methionine was 
used, and samples were taken every 20 seconds after 
addition of the chase mixture unless otherwise indicated. 
Each sample was transferred immediately into an Eppendorf 
tube containing gel loading sample buffer preheated to gooc 
as described. The samples were analyzed by 
SDS-polyacrylamide gel electrophoresis using 12% gels 
according to Laemmli (22); the gels were fixed in 10% 
acetic acid, 50% ethanol before drying and exposing to 
Kodak XRS film at room temperature. Autoradiograms were 
traced using a Cary 219 spectrophotometer with the 
appropriate attachments. 
Results and Discussion 
Three mutants in the region of the active site of beta 
lactamase with the sequences ser70-ser71-, thr70-thr71-, 
and thr70-ser71-, have been obtained as described in previ-
ous chapters; all three have been shown to cross react with 
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antibody raised against native wild type beta lactamase 
(23), but only one of them (-ser70-ser71-) is catalytically 
active. All three mutants appear to be more susceptible to 
proteolytic damage than the wild type enzyme during the 
early stages of purification (23), and it is only possible 
to obtain good yields when the host cells are cultured at 
or below 3ooc and the cell extracts are kept cold 
throughout the early stages of purification. This is in 
contrast with the wild type enzyme which is quite stable 
even if grown at 370, and handled at higher temperatures. 
These observations led to the conclusion that a more 
thorough study of the functions and physiology of these 
mutants would be in order, since very minor, conservative 
changes in protein sequence produced, in addition to the 
predicted effects on catalysis, some unexpected changes in 
other properties of the enzyme. Recent results (24) 
indicate that this is not an isolated phenomenon, and that 
seemingly inocuous point mutations may be disastrous for a 
protein's expression by simply making it more sensitive to 
proteases. Indeed, in some cases the rate of proteolysis .in 
YiYQ could be greater than the overall rate at which the 
protein is synthesized thereby giving the false appearance 
that the mutant protein is functionally inactive. 
In order to compare the rate of processing of the wild 
type and mutant beta lactamase precursors, the genes for 
the mutant beta lactamases were transferred to a previously 
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characterized phage system(l2), and pulse labeling and 
pulse chase experiments were done. Other systems such as 
maxi cells (18) could be used for the same purpose, but the 
one used here is the same one used in prior beta lactarnase 
studies. 
Phage-specified proteins are easily identified by 
80S-polyacrylamide gel electrophoresis because they can be 
labeled specifically after infection of a host that has 
been irradiated with ultraviolet light. Koshland and 
Botstein used this method to investigate the synthesis and 
maturation of beta-lactamase in s. typhirnurium; the 
structural gene for beta lactamase had been previously in-
corporated (12) into the bacteriophage P22 as a simple sub-
stitution of the beta lactamase structural gene for the 
dispensable secondary immunity region(immi) of P22. The 
active site mutants of beta lactamase were transferred to 
this phage derivative, designated P22-bla, as described 
below and the resulting phage strains were used in labeling 
experiments. 
Transfer of active autants: 
s. typhimurium DB4673 was transformed with pBR322-R2, 
the plasmid encoding the mutant beta-lactmase gene of se-
quence -ser70-ser71-. The resulting ampicillin resistant 
strain was subsequently infected at a multiplicity of in-
fection of 0.1 pfu/cell with phage P22bla-4393, a strain 
carrying a large deletion in the beta lactamase gene, which 
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encompasses the region of the active site. Phage progeny 
from this infection were used to infect strain DB6142, a 
polA mutant in which the plasmid cannot replicate, at a 
multiplicity of infection of 0.1. After plaque purifica-
tion, the phage progeny was used to infect cells at a mul-
tiplicity of infection of 10, and ampicillin resistant 
lysogens were selected on L agar plates containing 50 ug/ml 
ampicillin. After colony purification of the lysogen, it 
was cultured in broth and induced by ultra violet light 
irradiation. The resulting phage progeny was plated and a 
single plaque was used to infect a 100 ml broth culture to 
prepare phage stock by standard procedures. 
Transfer of inactive mutants: 
A strain DB4673 lysogen of the phage P22-bla 1752 
(Ampr, wt), was transformed with plasmid DNA from each of 
the two inactive mutants of beta lactamase (-thr70-ser71-
and -thr70-thr71-). After transformation, the lysogen was 
induced and the phage progeny was titrated and used to in 
feet strain DB6142 at a multiplicity of infection of 10. 
These cells were plated on L agar containing a low amount 
(2 ug/ml) of tetracycline, and incubated at 37oc until some 
colonies began to appear (this took 48 hours). Presumably 
these slightly tetracycline resistant colonies had in the 
bacterial chromosome a cointegrate of the plasmid and the 
phage DNA of the form -bla+-tc+-bla-; the low level of 
tetracycline resistance would be due to 
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the fact that these cells carry a single copy of the 
tetracycline resistance gene as opposed to 20 to 30 copies 
when the gene is encoded by a high copy number plasmid. 
Such a cointegrate when induced should give rise to two 
kinds of P22bla phage: one carrying the wild type (Ampr) 
alele, and one carrying the mutant (Amp-) alele of the beta 
lactamase gene. The presumed cointegrate was cultured in 
broth, induced by ultraviolet light irradiation, and plated 
on a combination of two tester strains designed to detect 
both Ampr and AmpS strains using a color reaction (see 
Methods). As expected, both red and colorless plaques were 
obtained; single colorless plaques (AmpS) were replated and 
then used to prepare phage stock. The AmpS phenotype of the 
phage accompanied by the occurrence of precursor and mature 
forms of beta-lactamase demonstrated in labeling 
experiments {see below) was considered evidence that the 
transfer of the mutant beta lactamase genes had taken 
place. 
Pulse chase experiments: 
Labeling of phage encoded proteins and pulse chase ex 
periments were done in the conditions described in the 
methods section. 
At 37o.c the incorporation of label into both precursor 
and mature forms of beta lactamase is rapid, so that even 
sampling every 15 seconds, after a 30 second pulse of 
35s-methionine, it is difficult to observe the 
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rate of processing accurately. Experiments done at this 
temperature did not reveal any differences between the 
processing of the wild type enzyme and any of the three 
active site mutants. In order to determine whether there 
were subtle differences, the experiments were carried out 
at 30°C for one of the mutants, since the process is slower 
and can be observed with greater resolution. 
Figure IV-1 is an autoradiogram of 35s-methionine la 
beled products of a typical pulse chase experiment analyzed 
by SDS polyacrylamide gel electrophoresis. A wild type con-
trol and the active mutant R2 (ser70-ser71-) are shown side 
by side ; each lane represents a sample taken at the 
specified time after the chase was initiated. The intensity 
of the bands was measured by doing a densitometer tracing, 
and integrating each peak. Figure IV-2 shows the quantita-
tive result; each point was normalized to the sum of the 
label present in each lane of the gel. There is no signifi-
cant difference between the rate of processing of the mu-
tant and the control, and this was reproducible in three 
independent experiments. 
Similar results were obtained with the two inactive 
mutants. Figures IV-3 and IV-4 show the results of pulse 
chase experiments done with the phage encoded mutant 
-ser70-->thr, and the double mutant ser70-->thr, 
thr71-->ser respectively. The results shown in figure IV-4 
are unfortunately obscured by background labeling of cellu-
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FIGURE IV-1 
Autoradiogram of 35s-methionine labeled proteins from a 
pulse-chase experiment comparing the rate of processing of 
mutant beta-lactamase thr71-->ser. Phage infected cells 
were pulse-labeled for 30 seconds and chased with 
chloramphenicol; samples were taken at different times 
after the chase and analyzed by gel electrophoresis through 
a 12% polyacrylamide SDS gel in reducing conditions. Lane 
(a) is a control infected with a phage strain carrying a 
large deletion in the beta-lactamase gene. Lanes (b) 
through (i) are extracts from cells infected with phage 
carrying the mutant beta-lactamase gene R2 (thr71-->ser); 
the length of the chase, in seconds, for lanes (b) through 
(i) respectively was 10, 30, 50~ 70, 90, 120, 150, and 300. 
The same time intervals were used for the control infected 
with phage carrying the wild type beta-lactamase gene in 
lanes (j) through (q). The labeling and chase were done at 
30°c. 
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Quantitation of pulse-chase analysis of wild type and 
mutant beta-lactamase gene products. 
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Autoradiogram of 35s-methionine labeled proteins from a 
pulse-chase experiment comparing the rate of processing of 
mutant beta-lactamase ser70-->thr. The experiment was done 
as described in the text and in Figure IV-1. Lane (a) is a 
control infected with a phage strain carrying a large 
deletion in the beta-lactamase gene. Lanes (b) through (i) 
are extracts from cells infected with phage carrying the 
mutant beta-1actamase gene (ser70-->thr); the length of the 
chase, in seconds, for lanes (b) through (i) respectively 
was 10, 30, 50, 70, 90, 120, 150, and 300. The same time 
intervals were used for the control infected with phage 
carrying the wild type beta-lactamase gene in lanes (j) 




Autoradiogram of 35s-methionine labeled proteins from a 
pulse-chase experiment comparing the rate of processing of 
mutant beta-lactamase ser70-->thr/thr71-->ser. The 
experiment was done as described in the text and in Figure 
IV-1. The labeling and chase were done at 37oc. 
Panel A: Lane (a) is a control consisting of uninfected 
cells; lane (b) is a control infected with a phage strain 
carrying a large deletion in the beta-lactamase gene. Lanes 
(c) through (j) are extracts from cells infected with phage 
carrying the wild type beta-lactamase gene ; the length of 
the chase, in seconds, for lanes (c) through (j) 
respectively was O, 30, 60, 90, 120, 150, 180 and 300. 
Panel B: Lane (a) is a control infected with phage carrying 
a partially deleted beta-lactamase gene. Lanes (b) through 
(m) are extracts from cells infected with phage carrying 
the mutant beta-lactamase gene (ser70-->thr); the length of 
the chase, in seconds, for lanes (b) through (m) 
respective1y was 0, 30, 60, 90, 120, 150, 180 240, 300, 
360, 420 and 480 . 
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lar proteins, as well as by poor electrophoretic resolution 
of precursor and mature beta lactamase, but there is no 
apparent indication of any dramatic difference between the 
rate of processing of the wild type and the mutant protein. 
(Attempts to repeat the experiment some months later were 
unsuccessful because after preparing fresh phage stock the 
beta lactamase gene apparently had been lost. Since it 
seemed unlikely that any striking differences would be 
found, the transfer of this mutant to phage P22bla was not 
repeated.) 
To summarize, of the three beta lactamase active site 
mutants that I have obtained only one retains catalytic 
activity whereas the other two are inactive. Another active 
site mutant of beta lactamase, thiolactamase, has been re-
ported in the literature and may represent the only substi-
tution at position 70 which gives an active enzyme (23). 
The three active site mutants appear to be less stable than 
the wild type protein, and the active revertant, in addi-
tion, has a reduced kcat/Km value for benzylpenicillin 
{23). On the other hand, the beta lactamase (cys77-->ser) 
mutant lacking the disulfide bond is active and stable in 
normal assay conditions (kinetic parameters have not been 
determined accurately yet, but preliminary results indicate 
that any differnces with the wild type enzyme will be 
small). 
It appears that the disulfide bond is only incidental, · 
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in that it is not required to maintain the enzyme in its 
native conformation, since an active conformation can be 
regained by the cys77-->ser mutant after thermal denatura-
tion (23). When a crude extract from either the wild type 
or the cys77-->ser mutant strain, containing beta lactamase 
and other periplasmic proteins, including some protease(s), 
is assayed at different temperatures ranging from 3ooc to 
6ooc, the following takes place: both wild type and mutant 
enzymes suffer a small but comparable loss of ac-
tivity as the temperature is increased from 3ooc to sooc. 
At approximately ssoc the activity of the mutant enzyme 
drops rapidly, while that of the wild type enzyme continues 
to lose activity at a lower rate as temperature is 
increased. If the heat inactivated mutant enzyme is cooled 
again to 3ooc at least 50% of the activity is regained , 
indicating that the loss of activity was due to unfolding 
of the protein rather than proteolysis. In contrast, if the 
active revertant (-ser70-ser71-) is subjected to thermal 
denaturation in similar conditions, it loses activity 
rapidly above 4ooc. In this case, the loss of activity is 
irreversible, due to proteolysis (23). This difference 
would seem to indicate a change in the unfolding kinetics 
of the active site mutant with respect both to the wild 
type and to the cys77-->ser mutant. On the other hand, the 
initial stages of the unfolding pathway are probably very 
similar in both the wild type and the mutant 
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without the disulfide bridge. The other two active site 
mutants which are inactive also appear to be more sensitive 
to proteolytic damage during purification than the wild 
type enzyme, but they have not been charactrized further in 
this respect. 
How does this speak of the structure of beta lactamase 
and its mechanism ? The thermal stability of a protein is 
determined by numerous parameters, and one must distinguish 
between those that influence the overall stability or, in 
other words, the work required to transfer the protein from 
the native state to the completely denatured state, and 
those that affect the stability of the native protein and 
are responsible for producing local, transient unfolding in 
the native protein • For small globular proteins the 
thermal denaturation can be considered a two stage 
cooperative transition which occurs at a characteristic 
temperature (24). Below this melting temperature, 
noncooperative predenaturational changes occur, and the 
frequency of these local changes in compact structure 
increases with temperature (25). Hydrogen exchange studies, 
used to judge how local unfolding brings internal groups 
into contact with the solvent, indicate that in many cases, 
different peptide hydrogens are exchanged at different 
rates, probably as a result of the difference in unfolding 
energies for different parts of the protein (24). The 
aminoacid substitutions at the active site of beta-lac-
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tamase may have the effect on the enzyme's stability of 
increasing the rate of local transient unfolding below the 
melting temperature, thus making some regions of the enzyme 
more accessible to solvent and to proteolytic digestion. In 
the case of the active mutant thr71-->ser, for example, the 
removal of a methyl group may have the effect of reducing 
the number of favorable hydrophobic interactions that sta-
bilize that region of the protein, allowing greater local 
mobility; on the other hand, the addition of a methyl group 
in one case and its repositioning in another may have simi-
lar destabilizing effects on the local packing in the two 
inactive mutants, ser70-->thr and ser70-->thr;thr71-->ser. 
In contrast, the mutant lacking the disulfide bond 
behaves very much like the wild type enzyme at lower tem-
peratures and this can be easily understood if one consid-
ers that the contribution of a disulfide bond to the sta-
bility of the protein is of an entirely different nature. 
As J. M. Thornton pointed out (19) most available evidence 
suggests that disulfides do not dictate the folding of the 
polypeptide chain, but they do contribute to the stability 
of the folded protein by reducing the entropy of the dena-
tured state still containing the intact disulfide(s), re-
lative to that of the folded protein, as contrasted to the 
entropy of a denatured state in which the disulfides have 
been removed. The contribution of a disulfide bond to the 
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overall stability of a protein at temperatures and in 
solvent conditions that favor the folded native 
conformation is negligible. Therefore, the reduced 
stability of the cys77-->ser mutant should only be manifest 
at or near the melting temperature if no local instability 
has been introduced into the protein by the side chain 
substitution; this appears to be the case. Often, disulfide 
bridges occur in proteins that have to function in harsh, 
sometimes unpredictable extracellular environments (Eg., 
trypsin, chymotrypsin, trypsin inhibitor, etc.), and such 
stabilizing cross-links contribute to the preservation of 
the proper folding even in the presence of potentially 
denaturing conditions. Interestingly, in the case of the 
four class A beta lactamases of known sequence, the E. coli 
enzyme is the only one with a disulfide bond. There does 
not seem to be any obvious selective advantage for E. coli, 
and perhaps the existence of these class A beta lactamases 
is a case of divergent evolution from an ancestor which 
itself evolved to operate at a higher temperature or in an 
otherwise harsher environment. 
The alterations in the three dimensional structure of 
beta-lactamase produced by the substitutions at the active 
site, are probably subtle since the active revertant is 
still a relatively efficient enzyme, and there is no effect 
on the maturation and secretion of the enzyme. The effects 
of these substitutions in the inactive mutants can almost 
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certainly be attributed entirely to the functional proper-
ties of the residues present at position 70, and only 
marginally to changes in the tertiary structure. 
The reduced value of kcat and slightly increased Km for 
benzylpenicillin with the active revertant R2, indicate 
that the effect of the mutation thr71-->ser is primarily to 
decrease the ability of the mutant enzyme to stabilize the 
transition state relative to the enzyme bound substrate 
although substrate binding is also very slightly poorer. In 
the inactive mutants, however the determining factor is 
clearly that a secondary hydroxyl of threonine is not capa-
ble of catalyzing the reaction, probably due to steric hin-
drance by the methyl group. The sulfhydryl group of 
thiolactamase (26), a primary nucleophile, does catalyze 
the reaction as does the primary hydroxyl of serine. No 
other residues have been found to be active at position 70 
and no compensating mutations have been found (Chapter III) 
that restore activity when threonine is present at position 
70. The complete lack of activity of the double mutant 
ser70-->thr; thr71-->ser, indicates that the residue at 
position 71 cannot substitute for the serine at 70 in pro-
viding the nucleophile that opens the beta lactam ring, 
confirming the assignment of ser70 as the catalytic residue 
in the wild type enzyme. 
A more detailed interpretation of these results in 
terms of the structure of the protein will require the long 
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awaited high resolution crystal structure which still has 
not been solved. A more detailed understanding of the 
changes in the catalytic mechanism of these mutant proteins 
will require further studies with different substrates and 
inhibitors, in order to establish the appropriate comparis-
ons with the wild type beta lactamase. Of particular in-
terest will be the effect of these structural changes in 
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PHOSPHOGLYCERATE KINASE: AN INTERESTING SYSTEM 
TO PROBE STRUCTURAL REQUIREMENTS 
FOR PROTEIN FUNCTION. 
INTRODUCTION 
Phosphoglycerate kinase (PGK) catalyses the phosphoryl 
transfer reaction 1,3-diphospho-D-glycerate + ADP---> 
3-phospho-D-glycerate + ATP. It is an enzyme that has been 
purified to homogeneity from a wide variety of sources, anrl 
has been studied intensively for more than thirty years 
(1,2). PGKs obtained from different sources are invariably 
monomers with molecular weights of about 45,000, having 
similar catalytic properties and a highly conserved amino 
acid composition (1,2). The entire amino acid seauences of 
the yeast (3), horse muscle (4), and human red blood cell 
(5) proteins are known, and there is remarkable homology 
between the equine and human PGKs, with only 14 amino acid 
differences in a 416 residue chain; both have about 65 % 
homology with the yeast enzyme. The structural genes for 
the yeast (6,7) and the human (8,9) enzymes have been 
cloned and their DNA sequences have also been determined. 
High-resolution X-ray studies on the yeast (3) and 
horse muscle (4) enzymes have yielded detailed structural 
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information, and it is clear that the enzymes from both 
sources are highly homologous . The sinqle polypeptide 
chain folds into two widely separated domains of 
approximately equal size corresponding to the C-terminal 
and N-terminal halves of the polypeptide chain, which are 
connected by a narrow waist through which the polypeptide 
chain passes only twice (the last few C-terminal residues 
complete theN-terminal domain). 
It has only recently become possible to generate 
deliberately and accurately any predetermined variant of 
a protein by introducing changes in the primary sequence 
that can range from specific amino acid substitutions to 
major restructuring. This ability, made possible by the 
now widely applied techniques of in vitro mutagenesis 
and recombinant DNA, has widened the range of 
structure-function relationships that can be investigated , 
since we are no longer limited to the study of naturally 
occurring variants or to those variants that can be 
obtained by random mutagenesis and classical genetic 
methods (10). 
The prerequisites for deliberately altering the 
sequence of a naturally-occurring protein to study the 
relationship between its structure and function are to 
have the structural gene cloned and expressed in a 
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suitable vector-host system, to know the entire DNA 
sequence of the gene, and (for some forms of specific 
mutagenesis) to have the ability to synthesize oligo-
deoxynucleotides. In addition, it is highly desirable 
to have available detailed structural and mechanistic 
information, preferably from more than one source, to 
design the most informative changes in primary structure 
and to subsequently interpret the results accurately. 
The PGK system meets these requirements . 
The gene for the yeast enzyme is cloned and expresserl 
(7) and its entire sequence has been determined (8). The 
structural gene for the human X-chromosome-linked enzyme 
has been cloned by J. Singer, et al., in A. D. Riggs's 
laboratory (8). (A full-length eDNA clone has been 
obtained recently (J. Singer-Sam, personal communication.) 
Its entire sequence is known (9) although it has not been 
expressed. As mentioned above, detailed structural 
information is available for the yeast enzyme and for 
the human enzyme by virtue of its homology with the 
horse-muscle enzyme. Furthermore, enzymatic phosphoryl 
transfer reactions have been the subject of many studies 
at the molecular, physical-organic chemical level, and a 
variety of methods have been devised to scrutinize their 
mechanism (11). 
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These facts, namely, the availability of structural 
genes from two very different eukaryotic sources for an 
enzyme whose structure and catalytic mechanism have been 
intensively studied (1-5,13-22), make this a system that 
is ideally suited for directed mutagenesis experiments. 
In addition to the study of specific problems in 
catalysis, this system is useful for experiments designed 
to shed light on general sequence requirements for 
different forms of secondary and tertiary structure. 
It also affords an excellent opportunity to study the 
phenomenon of domain movement , which is possibly a general 
requirement of kinase reactions (12). 
The types of mutagenesis that can be done with this 
system fall into three categories: 
1. Specific amino acid substitutions. 
2. Random amino acid substitutions within a 
particular segment of the gene. 
3. Major restructuring. 
Oligonucleotide-directed mutagenesis is ideally 
suited to study a glutamate-histidine interaction that 
is postulated to play an important role. Substantial 
evidence supports domain movement on binding the two 
substrates, and it has been suggested that weakening of 
this interaction (glu 190-his 388) is the initial step 
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in domain movement. The substitution of glutamate 190 
in the yeast enzyme by (a) glutamine, (b) aspartate, 
or (c) asparagine would be informative , because it 
would subtly alter the nature of the interaction while 
minimizing the changes in the size and shape of the side 
chain at position 190 . 
A rotation of one domain with respect to the other 
about residue 187 in the yeast enzyme or the equivalent 
region in the horse enzyme is consistent with experimental 
observations (14,4); therefore this position (and neiqh-
boring residues) is another site of considerable interest. 
For example, substitution of leucine 187 by proline would, 
in all likelihood, interfere with domain movement if this 
is indeed the "hinge" reqion it appears to be. 
Segment-directed mutagenesis in this reqion probably 
would also prove fruitful, since many variants could be 
produced, and their ability or inability to undergo the 
postulated conformational change could be correlated with 
amino acid substitutions and provide information on the 
nature of the hinge region . Mutations that result in a 
loss of function can be used later to identify any 
alternative residues capable of restoring biological 
activity. This sort of data would be a useful addition to 
the growing body of information used to predict protein 
1~ 
structure from primary sequence. 
Major restructuring of a protein can also provide 
information, especially on the role of entire regions. 
Since the genes for human and yeast enzymes are available, 
the construction of human-yeast hybrid proteins is 
possible and could be informative. A protein consisting 
of an N-terminal domain from one source and a C-terminal 
domain from the other source would be interesting, and 
its activity or inactivity would give information on the 
degree of sequence variation that can occur without 
disruption of the overall structural and functional 
requirements of the protein. If the resulting hybrids 
are inactive, the requirements for restoration of activity 
could be studied. 
When the genes for a given protein are available from 
more than one source but no detailed structural information 
exists, the construction of hybrids could be used to 
deter~ine whether the extent of sequence conservation is 
sufficient to produce homologous three-dimensional 
structures and to determine whether nonconserved residues 
are critical or not. Performing this experiment in a 
system for which high-resolution X-ray data is available 
would test the validity of these assumptions. 
These are only a few examples of mutagenic experi-
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ments that could be done on this system. In the following 
section, I will describe in detail the strategy for 
cloning the human-yeast hybrid genes, and for introducing 




CONSTRUCTION OF HUMAN-YEAST PGK HYBRIDS 
The separation of PGK into two domains is clear, 
but defining a point in the primary sequence as the 
boundary between those two domains is somewhat arbitrary. 
The so-called waist region of the protein extends 
approximately from the carboxyl end of beta strand F 
in both the horse and the yeast enzymes to some point 
in alpha helix 7 in the horse enzyme, or to the equivalent 
helix V in yeast. At this point, the polypeptide chain 
crosses from the N-terminal domain to form the C-terminal 
domain. The last few C-terminal residues stack on the 
N-terminal domain, and contribute to the structure of the 
waist region as the polypeptide chain passes through it 
a second time (3,4). 
As a first approximation, one can chose the region 
that first passes through the waist region as the 
arbitrary boundary. Later one could refine this 
definition by taking into consideration in the construction 
of hybrids, that the last 10 to 12 C-terminal residues 
constitute part of the N-terminal domain, and that 
therefore they should have the same origin as the rest 
of that domain. Residues 184 through 186 in yeast (186 
through 188 in horse and human enzymes) are conserved 
in the three species, and connect beta strand F with 
148 
helix V (or 7). Because a splice in a conserved sequence 
would be the least disruptive, this appears to be a good 
choice. Although the amino acid sequence in this segment 
is conserved, the DNA sequence is not. Since there are 
no restriction sites conveniently located at this site, 
it is necessary to create a junction at this point by 
other means. 
Several techniques are available to accomplish this 
end, but one stands out because of its simplicity and 
effectiveness. In addition to its template-dependent 
polymerization activity, the Klenow fragment of DNA 
polymerase I fro~ E. coli is capable of digesting 
single-stranded DNA in the 3' to 5' direction (23), but 
digestion stops when a perfectly complementary double-
stranded region is reached. This property has been used 
to create blunt-ended junctions at a specific site in a 
DNA sequence with the aid of a synthetic oligodeoxy-
nucleotide that acts as an "editing primer" (24,25). 
The oligomer complementary to the DNA sequence at 
the site to be "edited" is designed so that its 5' end 
constitutes the junction that needs to be created. 
A suitable restriction fragment of a few hundred base 
pairs in length containing the region to be modified is 
heat-denatured and then chilled in the presence of excess 
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oligomer. The synthetic DNA is annealed specifically, 
and its 3' end is extended when DNA polymerase (Klenow 
fragment) and the four deoxynucleotide triphosphates are 
added, while the bases on the initial restriction fragment, 
which lie 3' to the annealing site, are digested. This 
reaction results in a double-stranded, blunt-ended DNA 
fragment, which extends from the 5' end of the oligomer 
(the junction) to the intact 5' end of the DNA strand that 
served as a template. In addition to this, if necessary, 
the sequence at the junction can be modified by designinq 
the oligonucleotide with an altered sequence at its 5' end. 
The 3' editing activity of DNA polymerase will digest any 
bases that are noncomplementary to the 5' end of the 
oligonucleotide, and will faithfully copy the sequence 
of the oligomer. These methods can be adapted to produce 
hybrids of the yeast and human PGK genes to be used later 
to direct the synthesis of hybrid PGK enzymes. 
The overall strategy is depicted in Figure 1. If 
both genes (or appropriate 5' and 3' terminal segments) 
are cloned sequentially in the same vector and in the 
same relative orientation, a double restriction digest 
can generate a fragment containing the vector and the 
terminal segments of each gene. Internal fragments of 
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restricted to produce specific cohesive ends that are 
compatible with those of the segments attached to the 
vector. A three-fragment ligation reaction will yield 
a circular DNA molecule consisting of the vector and a 
reconstructed hybrid PGK gene with the half correspondino 
to the N-terminal domain of the protein from one source 
. 
and the C-terminal half from another, precisely joined 
at a specific predetermined site in the sequence. 
Figure 2A shows an overall restriction map of the 
yeast and human PGK genes, including only those sites 
that pertain to the experimental strategy. Figure 28 
shows in detail the selected junction site, as well as the 
"editing" oligonucleotides. Because of the differences 
in the DNA sequence of the two genes, two junctions are 
needed to create the two hybrid proteins NhumanCyeast and 
NyeastChuman (where N and C represent the N-terminal and 
carboxy-terminal domains respectively). Therefore, four 
oli9onucleotides are required. The four editing reactions 
are shown in Figure 3. 
A Psti-Xbai fragment of the human qene, including 
all of the structural gene and parts of the 5' and 3' 
untranslated regions, can be cloned into the corresponding 
sites in the vector M-13 mpll, after removal of the 













































































































FIGURE 2 B 
Sequence of the selected junction site and of the editing 
primers. 
YEAST GENE JUNCTION SITE 
AlaAlaGlyPheLe~LeuGluLysGluLeu 
5 I GCTGCCGGTTTCTTG~TGGAAAAGGAATTG 3 I 
I I \ \ 
I I \ \ 
I I \ \ 
I I \ \ 
3 I CGACGGCCAAAGAAC5 I 5 I A 'ffiAAGAAGGAGCTG3 I 
BOMAN GENE JUNCTION SITE 
AlaGlyGlyPheLeiMetLysLysGluLeu 
5 I GCTGG'ffiGGTTTTTG~TGAAGAAGGAGCTG 3 I 
I I \ \ 
I I \ \ 
I I \ \ 
I I \ \ 
3 I GCACCACCCAAAAAC5 I 5 I A 'ffiAAGAAGGAGCTG3 I 
1_54 
in a Pvu I-Hind III fragment can be cloned by blunt-end 
ligation, either into the Pst I site 5' to the human gene, 
or into the Eco RI site 3' to the human gene, producing 
vectors NyCH and NHCY respectively. Clones carrying both 
genes can easily be identified by using the "editing" 
primers as hybridization probes. Since the yeast gene 
can enter each site in either of two orientations, the 
clones carrying it in the desired orientation must be 
identified, either by their restriction patterns or by 
hybridization to the "editing" oligonucleotides. 
Vector NyCH is digested with Kpni and Bgli, which 
have no target sites in the Ml3 sequence, but do have 
sites on the yeast and human genes respectively. The 
largest resulting fragment is used in a three-fragment 
ligation reaction with yeast Kpni-blunt fragment (No. 1 
in Fig. 3) and human blunt-Bgl I fragment (No. 4 in Fig. 3) 
that resulted from "primer-editing" reactions. 
Vector NHCY can be used in a similar set of 
reactions, digesting with Hindi!! and Bali in this 
instance. The vector fragment, the human Hind III-blunt 
fragment (No. 3 in Fig. 3) and the yeast blunt-Hha II 
fragment (No. 2 in Fig. 3) are ligated to yield the 
desired hybrid gene. Figure 4 summarizes these reactions. 
The three-fragment ligation reactions, as well as 
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Figure 3 Primer editing reactions 
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the primer-editing reactions, have been reported to be 
efficient {24,25). The choices of restriction sites and 
fragments from each gene to be used in generating these 
two hybrids have been dictated primarily by practical 
considerations, such as the occurrence of target sequences 
in the human and yeast genes, and the availability of 
restriction enzymes from commercial sources. Evident 
alternatives do exist, but the proposed strategy is 
designed to utilize existing resources to their best 
advantage, using as few steps as possible to accomplish 
the desired objective. If having both the yeast and 
human PGK genes in the same vector resulted in stability 
problems because of homology in the DNA sequences {in 
spite of being in the same relative orientation), it 
would be simple to modify the strategy to overcome this 
by starting with vectors having single inserts. 
Once the hybrid genes are obtained and their 
sequences verified, it will be necessary to transfer 
them to an expression vector. The yeast gene already 
has been adapted for expression in both yeast and E, coli 
{2,26) and work is underway to obtain expression of the 
human gene in E. coli {27) and in yeast {26). Therefore, 
once the NyCH and NHCY hybrids are obtained it should be 
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in pgk- strains (6) and for purification of the resulting 
proteins by adapting existing procedures. There are four 
methionines in the yeast enzyme and fourteen in the human 
enzyme; therefore, each hybrid protein would give rise to 
different sets of peptides, distinct from those generated 
by either of the parent proteins when treated with 
cyanogen bromide. This will be useful to confirm the 
sequences at the protein level. 
If the resulting enzymes are active, the initial 
characterization should focus on determining kinetic 
parameters, stability to heat and denaturing agents, 
etc., in an effort to establish what differences and 
similarities exist between the hybrids and the parent 
enzymes. If the hybrid proteins are inactive, it would 
be more interesting initially to try to determine what 
changes in the structure (if any) would restore catalytic 
activity, although ligand binding and stability properties 
should also be determined to assess the extent of the 
structural disruption responsible for loss of activity. 
In either case, the determination of the structure 
by X-ray crystallography should be undertaken. The 
detailed nature of the experiments that should be done 
to characterize the resulting proteins will be determined, 
to some extent, by their properties, and a further 
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description of the possibilities and experimental 
approaches designed to explore them are beyond the 




STUDY OF THE EFFECT OF VARIOUS SPECIFIC AMINOACID 
SUBSTITUTIONS ON THE MECHANISM OF DOMAIN 
MOVEMENT IN PHOSPHOGLYCERATE KINASE 
The carboxyl group of glutamate 190 in helix V of the 
amino terminal domain of yeast PGR extends toward beta 
sheet N of the carboxyl domain, forming an interesting in-
teraction with histidine 388. H. c. Watson et. al. proposed 
a "trigger mechanism" in which the cumulative effects of 
small conformational changes, which probably occur on bind-
ing of both substrates, weaken the interaction between 
glul90 and his388 thus initiating domain movement (3). 
The importance of the interaction between glutamate 190 
and histidine 388 in the mechanism of domain movement of 
phosphoglycerate kinase could be better understood if 
presumably non disruptive substitutions are introduced at 
one of the two sites. The proposed substitutions are 
glul90-->gln, glul90-->asp and glul90-->asn which would 
would probe the importance of the charged group and the 
length of the side chain in forming this interaction. The 
resolution of the crystallographic data (2.5 Angstroms) 
leaves the precise relative orientation of the two side 
chains of interest somewhat uncertain, but they have been 
represented as being hydrogen bonded (3). Visual inspection 
of a graphic representation of the PGK molecule in an Evans 
and Sutherland PS 300 graphics terminal revealed no other 
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residues in the waist region sufficiently close for any 
obvious interactions with either residue; if the glutamate 
residue is substituted in the computer by the shorter, less 
flexible aspartate, the carboxyl group can still come into 
close proximity with the histidine residue in at least one 
possible side chain conformation. This suports the idea 
that these changes would not disrupt the protein's 
structure. 
Since these substitutions are likely to weaken the 
his-glu interaction, in the resulting mutant proteins 
domain movement would be facilitated, and this would have 
the effect of producing a more active enzyme if the pro-
posed mechanism is correct. 
The yeast PGK structural gene is contained in an Eco 
RI-Hindiii restriction fragment which can be subcloned into 
the single stranded phage vector Ml3mp9 for the purposes of 
introducing the specific substitutiuons. Synthetic 
oligonucleotides can be used to mutate the GAA glutamate 
codon to CAA (gln), AAC (asn) or GAC (asp) by 
oligonucleotide-directed mutagenesis as described in 
Chapter II of this thesis. A computer search for homologies 
between the oligonucleotides and both the vector plus 
strand and the cloned fragment should be done; if this 
reveals homologous competing sites, a shorter fragment of 
the PGK gene and/or a different vector can be used. 
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After obtaining and confirming the mutations by DNA 
sequencing, the gene fragments should be introduced into a 
yeast expression vector and used to transform an appropri-
ate pgk- yeast host (6) in order to produce the mutant 
proteins. 
Unless the aminoacid substitutions are destabilizing to 
the proteins, or alter their folding pathway making them 
more sensitive to proteolysis, these mutant enzymes should 
be active and produced in large quantities. If they are 
active, purification and determination of kinetic parame-
ters should be undertaken in order to assess the nature and 
magnitude of the differences between the mutants and the 
wild type enzyme. Inactive mutants in this case would not 
be informative about domain movement, since they would 
probably be folding mutants, but they could be used to gain 
understanding of the requirements for proper folding, if it 
were possible to produce them in adequate amounts. If ac-
tive mutants are obtained, they should be crystalized for 
structure determination; it is likely that crystals of ac-
tive mutants would be isomorphous with those of the parent 
enzyme, simplifying the problem of structure determination. 
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SOME APPROACHES TO INCREASE UNDERSTANDING OF THE 
MECHANISM OF TELOMERE REPLICATION 
The replication of of the ends of linear eukaryotic 
chromosomes is a problem that has not been solved although 
several hypotheses have been put forth (1). Since all known 
DNA polymerases require a primer, when a linear DNA 
molecule is replicated, a 5' terminal gap is generated in 
the daughter strand when the primer is removed after 
initiation of synthesis. Several proposed models to explain 
the mode of replication of chromosomal ends are variations 
of the idea that palindromic sequences, or sequences 
capable of forming hairpin loops at the end of the 
replicating chromosome are involved, and that specific 
nicks are introduced at some point to resolve the daughter 
strands. 
Progress in understanding the mode of telomere replica-
tion has been facilitated recently by the construction of 
self replicating linear plasmids with Tetrahymena macronu-
cleus ribosomal DNA ends capable of functioning as 
telomeres in yeast (2), and the cloning of yeast telomeres 
using one such linear plasmid (2). 
The structure of linear DNA termini appears to be very 
similar in many lower eukaryotes, and within a same orga-
nism, it is likely that all telomeric ends are identical 
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(1). The structure of Tetrahymena rDNA telomeric ends has 
been studied and found to contain tandem repeats of the 
hexanucleotide 5'-CCCCAA-3 1 ; several single stranded, one 
nucleotide gaps were found at specific sites in the C4A2 
strand and one in the complementary G4T2 strand. 
Interestingly, when these ends function as telomeres for 
linear plasmids in yeast, the position of these gaps is 
altered to a pattern characteristic of yeast telomeres, 
which is similar but not identical (2). No covalently, or 
tightly bound proteins have been isolated (3), but some 
mechanism for maintaining the specific gaps and replicating 
these ends must exist which relies on some specialized set 
of enzymatic activities. These enzymes will of necessity 
have affinity for the substrate, (C4A2)n, and therefore it 
should be possible to isolate them by affinity 
chromatography using a similar method to that used by 
Nordheim et al. (4) to isolate z DNA binding proteins. 
In order to prepare an affinity column for this purpose 
it would be necessary to prepare a relatively large amount 
of DNA, so synthesizing both strands of an oligomer would 
probably be the more straightforward approach. The number 
of repeats of the hexanucleotide present in the synthetic 
oligomer would be limited by practical considerations and 
could not exceed six or seven without impacting 
significantly on the overall yield of the synthesis. The 
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number of repeats present in the Tetrahymena rDNA ends is 
of the order of 50, so by using a much shorter segment of 
DNA one runs the risk of not taking full advantage of all 
possible contacts between DNA and protein(s); however, it 
is hard to envision a situation in which a protein would 
not bind preferentially to a fragment of its normal 
substrate, unless a very complex tertiary structure of the 
DNA were required for binding. Since the proteins that 
would be interesting are those involved in mediating the 
replication of the termini, it seems reasonable to assume 
that this is not the case. 
Tetrahymena extracts enriched for nuclear proteins 
could be fractionated on an affinity matrix derivatized 
with the synthetic DNA duplex and any proteins obtained in 
this way could be further purified in a second affinity 
fractionation step using carrier E. coli DNA in order to 
reduce contamination by proteins non specifically bound to 
DNA. Any fractions with C4A2 binding activity should be 
assayed for nuclease activity, the ability to excise nu-
cleotides from double stranded DNA, and their ability to 
alter the electrophoretic mobility of DNA, using both ran-
dom sequence DNA and (C4A2)n as substrates, as an initial 
form of characterization. Further biochemical 
characterization would depend on preliminary findings. 
In this way, by identifying some of the enzymatic ac-
tivities responsible for telomere replication it would be 
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possible to refine the existing models. 
Using synthetic DNA for this experiment would have the 
added advantage of providing material for physical and 
chemical characterization of this CCCCAA sequence to 
determine whether it dictates some unusual sequence depen-
dent secondary or tertiary structural characteristic. 
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STUDY OF THE POSSIBLE ROLE OF 
Z-ONA IN DEVELOPMENT 
The salt induced, cooperative helix-helix transition 
that the alternating deoxypolynucleotide poly d(GC)·poly 
d(GC) undergoes in solution was first described by Pohl and 
Jovin (1972) (1). The transition can be induced by raising 
the concentration of NaCl (transition midpoint 2.7 M), 
MgCl2 (trasition midpoint 0.8 M) or by adding ethanol to a 
final concentration of 60% v/v. It produces virtually 
complete inversion of the CD spectrum (1,2) and substantial 
changes in the ORD (1) and laser Raman spectra (3) of the 
alternating copolymer. 
The characteristics of the high salt form of oligo 
d(GC) were studied further by Patel .e..t .a.l. (1979) (4) using 
proton and 3lp NMR solution methods in an attempt to 
elucidate structural aspects of the conformation. The NMR 
data yielded information on the nature of the 
conformational transition and some major features of the 
high salt helix. It was shown to exhibit an A-DNA sugar 
pucker and glycosidic torsion angle at the purine residues, 
alternating with a B-DNA type sugar pucker and glycosidic 
torsion angle at the pyrimidine residues. The phosphate 
backbone formed by two types of alternating non-equivalent 
phosphates gave rise to two 3lp resonances, in contrast 
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to the single peak observed in the low salt, B 
conformation. 
When the crystal structures of d(CpG)3 and d(CpG)2 were 
solved (5,6,7) a novel left-handed conformation for DNA 
emerged: the atomic resolution data gave detailed 
information on the structure of the self-complementary 
oligomers as well as the organization of water molecules 
and ions found in the crystal structure. It became apparent 
that there is a family of closely related left-handed DNA 
conformations which can differ in specific ways, but which 
share certain major characteristics (8). In general, the 
structure is an antiparallel double helix with Watson-Crick 
base pairing and a left-handed helical sense. The guanine 
residues adopt a syn conformation relative to the 
corresponding deoxyribose, which is found in a C3' endo 
conformation. The cytsoine residues on the other hand are 
in the familiar anti configuration, associated with a de-
oxyribose that has C2' endo pucker as in B-DNA. The zigzag 
course pursued by the ribose-phosphate backbone led to the 
name Z-DNA. 
Right-handed B-DNA has a major and minor groove, but 
there is only a single groove in Z-DNA, analogous to the 
B-DNA minor groove. The outer, convex surface of Z-DNA is 
analogous to the concave major groove of B-DNA . The G-C 
base pair forms part of the outer surface of left-handed 
DNA, with the bases far more accessible to solvent and 
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ligands than in B-DNA: it has been shown that bromination 
of the C8 of guanosine as well as methylation of cytosine 
C5 stabilize the Z conformations (9,10). 
The assignment of Z conformation to the high salt form 
of alternating d(GC) has been made on the basis of the 
solution NMR data mentioned above, and a recent study of 
the laser-Raman spectra of crystals and solutions of 
d ( CpG ) 3 and so 1 uti on s of po 1 y d ( G C ) ( 11 ) . Th is con f o r m a-
tion does not appear to be restricted to alternating d(GC) 
since there is evidence that other alternating purine-py-
rimidine sequences can form left-handed helices. A Z-type 
conformation was observed for poly d(AC)•poly d(GT) by 
fiber diffraction methods (12) and changes in the CD spec-
trum of the same polymer can be induced in solution at high 
concentrations of CsCl or CsF (13,14). 
The potential role in biological systems of a reversi-
ble, sequence dependent conformational change in DNA could 
be extensive since it represents an additional mode of en-
coding biological information in the nucleotide sequence of 
DNA. Varied evidence supporting this idea is rapidly 
accumulating. Cytological data indicate the presence of DNA 
segments with z forming potential in several eukaryotic 
nuclei in species of Drosophila (9), Chironomus, Styloni-
chia, and several rat tissues (15, 16); proteins that bind 
Z-DNA specifically, have been isolated from Drosophila (17) 
and from SV40 minichromosomes (15); two z-compatible se-
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quences in the transcriptional enhancer region of SV40 ap-
pear to be required for enhancer function (18). The subject 
has been reviewed by Rich et al. (15) and these are only 
some of the more striking examples that indicate that Z-DNA 
does indeed have a biological role. How extensive a role it 
plays in the control of gene expression is yet undetermined 
and it would be interesting to design experiments to ad-
dress that question. 
In a cytological study of several different rat tissues 
(16) using specific anti Z-DNA antibodies, it was found 
that some nuclei are intensely stained whereas others are 
not. In particular, in the seminiferous tubules of the 
testes, where several developmental stages in the matura-
tion of spermatozoa are observed, only certain cell types 
at a particular stage of differentiation are stained with 
labeled anti Z-DNA antibodies. Although the significance of 
results obtained by staining fixed tissues should be 
interpreted with caution, this suggests a possible role for 
Z-DNA in development, and it would be interesting to find 
out whether this is the case by an independent approach. 
One can argue that in order to stabilize DNA in a z 
conformation in some cells and not in others Z-DNA binding 
proteins are differentially expressed in different cell 
types. Since a number of proteins that specifically bind 
Z-DNA have been isolated from Drosophila (17), it would be 
feasible to clone their genes in order to use them as by-
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bridization probes and investigate their expression at dif-
ferent stages in development. Either protein sequence in-
formation or antibodies against the Z-binding proteins 
should be available soon. 
If antibodies against Z-binding protein(s) become 
available first, then the method of choice would be to 
screen an expression library, constructed using a vector 
such as lambda gtll (21). 
With protein sequence data, synthetic oligonucleotide 
probes (19) can be designed to screen a eDNA library. If 
only very highly degenerate mixed oligomeric probes are 
possible due to the protein sequence, a longer (>50 bp), 
therefore more specific, unique sequence probe can be 
designed by chosing a single base at degenerate sites based 
on the preferred codon usage of the organism from which the 
library was made (20). Some "guesses" will be incorrect, 
but the added length of the probe should compensate for 
this, with the added benefit of greatly reducing the proba-
bility of obtaining "false positives", a problem commonly 
encountered when using short, mixed sequence probes. 
Once the gene is cloned and its identity is confirmed 
by comparison of its sequence to that of the protein, it 
can be used to study the expression of its product in 
different tissues and at different stages of 
differentiation, as well as to study the structure of the 
gene(s) in the genomic DNA. 
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PROPOS! TION V 
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A STUDY OF UNFOLDING AND REFOLDING OF 
E. COLI BETA LACTAl1ASE 
The mechanism of folding and unfolding of s. aureus 
beta-lactamase has been studied by a variety of methods, 
including circular dichroism, optical rotatory dispersion 
(1, 2), NMR (3), and UV difference spectroscopy (4, 5), 
using several denaturants such as urea, guanidinium 
chloride and some biguanide salts. 
These studies led to the identification of a stable 
unfolding intermediate predominant at intermediate concen-
trations of urea or guanidinium chloride, which is signifi-
cantly more expanded than the native state, but which has a 
substantial content of secondary structure (1, 2). NMR data 
indicate that the residues in the N terminal third of the 
molecule are affected by the transition from the native 
stateN, to the intermediate state H (4), and a multidomain 
model has been proposed for the structure of this protein 
which would allow a large change in shape in the intermedi-
ate state H if the domains or folding regions separate 
without themselves becoming unfolded (2). Additional stu-
dies by urea-gradient polyacrylamide gel electrophoresis 
(6) confirm the existence of state H and indicate that un-
folding proceeds by a two-state transition to fully unfold-
ed protein, but that refolding is complex and involves the 
formation of the partially folded intermediate H (7). 
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Urea-gradient electrophoresis is a useful technique 
that can yield a substantial amount of information regard-
ing the mode of folding and unfolding of a protein (6). A 
band of protein is subjected to electrophoresis through a 
gel slab in which a transverse gradient of denaturant has 
been established; thus a continuous band of protein mi-
grates in a direction that is perpendicular to the 
gradient. As the continuous band of protein moves electro-
phoretically under gradually varying conditions, a pattern 
is generated that can be interpreted in terms of the varia-
tion of protein conformation with the changing conditions. 
The technique is particularly useful in identifying confor-
mational states which are interconverted slowly relative to 
the duration of electrophdresis; some of the limitations 
are that this method may not be sensitive to small confor-
mational changes, and that not all conformational transi-
tions will produce a measurable difference in mobility. It 
has proven useful in the case of s. aureus beta-lactamase 
(7) which unfolds and refolds slowly at room temperature 
( 1) • 
S. aureus beta lactamase is a class A enzyme, according 
to Ambler's classification (8), whose sequence is 30% homo-
logous to that of the E. coli beta-lactamase. Their three 
dimensional structures are likely to be similar, particu-
larly since 19% of the residues are completely conserved in 
these and two other class A beta lactamases (8). It would 
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be interesting therefore to find out whether the unfolding 
and refolding of E. coli beta-lactamase is similar to that 
of the S. aureus enzyme. The latter has no disulfide 
bridges, therefore the initial comparison should be estab-
lished with the mutant of E. coli beta lactamase that lacks 
the single disulfide bond present in the wild type enzyme 
(Chapters II and IV of this work). 
This mutant E. coli beta-lactamase could be analyzed by 
urea-gradient electrophoresis, starting with either native 
enzyme or completely denatured enzyme, in similar condi-
tions to those used for the s. aureus enzyme. If evidence 
is found of similar behavior, the interpretation of results 
would be greatly aided by the large amount of information 
already available for the S. aureus enzyme. 
Subsequently, similar experiments could be carried out 
to compare the behavior of this mutant beta-lactamase to 
that of the wild type enzyme with its disulfide bond in-
tact, to determine how it influences the unfolding and in 
particular the refolding of the enzyme. Aquiring this kind 
of information about E. coli beta lactamase could help 
design experiments to understand the cause of the instabi-
lity observed in some of the other mutant beta-lactamases 
described in this thesis. Spectroscopic studies would prob-
ably be needed in addition, but this method appears to be 
a good initial step toward understanding the effect of 
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various mutations on the folding pathway of E. coli beta-
lactamase. 
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